id	sid	tid	token	lemma	pos
dpc-1565	1	1	dermatology	dermatology	NOUN
dpc-1565	1	2	:	:	PUNCT
dpc-1565	1	3	practical	practical	ADJ
dpc-1565	1	4	and	and	CCONJ
dpc-1565	1	5	conceptual	conceptual	ADJ
dpc-1565	1	6	dermatology	dermatology	NOUN
dpc-1565	1	7	practical	practical	ADJ
dpc-1565	1	8	&	&	CCONJ
dpc-1565	1	9	conceptual	conceptual	ADJ
dpc-1565	1	10	research	research	NOUN
dpc-1565	1	11	|	|	ADV
dpc-1565	1	12	dermatol	dermatol	ADJ
dpc-1565	1	13	pract	pract	NOUN
dpc-1565	1	14	concept	concept	NOUN
dpc-1565	1	15	.	.	PUNCT
dpc-1565	2	1	2021;11(3):e2021046	2021;11(3):e2021046	NUM
dpc-1565	2	2	1	1	NUM
dpc-1565	2	3	sodium	sodium	NOUN
dpc-1565	2	4	hypochlorite	hypochlorite	NOUN
dpc-1565	2	5	0.005	0.005	NUM
dpc-1565	2	6	%	%	NOUN
dpc-1565	2	7	versus	versus	ADP
dpc-1565	2	8	placebo	placebo	NOUN
dpc-1565	2	9	in	in	ADP
dpc-1565	2	10	the	the	DET
dpc-1565	2	11	treatment	treatment	NOUN
dpc-1565	2	12	of	of	ADP
dpc-1565	2	13	mild	mild	ADJ
dpc-1565	2	14	to	to	ADP
dpc-1565	2	15	moderate	moderate	ADJ
dpc-1565	2	16	acne	acne	NOUN
dpc-1565	2	17	:	:	PUNCT
dpc-1565	2	18	a	a	DET
dpc-1565	2	19	double	double	ADJ
dpc-1565	2	20	-	-	PUNCT
dpc-1565	2	21	blind	blind	ADJ
dpc-1565	2	22	randomized	randomize	VERB
dpc-1565	2	23	controlled	control	VERB
dpc-1565	2	24	trial	trial	NOUN
dpc-1565	2	25	azadeh	azadeh	NOUN
dpc-1565	2	26	dorostkar1	dorostkar1	PROPN
dpc-1565	2	27	,	,	PUNCT
dpc-1565	2	28	mehdi	mehdi	ADJ
dpc-1565	2	29	ghahartars1	ghahartars1	PROPN
dpc-1565	2	30	,	,	PUNCT
dpc-1565	2	31	mohammad	mohammad	PROPN
dpc-1565	2	32	reza	reza	PROPN
dpc-1565	2	33	namazi1	namazi1	PROPN
dpc-1565	2	34	,	,	PUNCT
dpc-1565	2	35	nafiseh	nafiseh	ADJ
dpc-1565	2	36	todarbary2	todarbary2	PROPN
dpc-1565	2	37	,	,	PUNCT
dpc-1565	2	38	maryam	maryam	PROPN
dpc-1565	2	39	hadibarhaghtalab1	hadibarhaghtalab1	PROPN
dpc-1565	2	40	,	,	PUNCT
dpc-1565	2	41	maryam	maryam	PROPN
dpc-1565	2	42	rezaee1	rezaee1	PROPN
dpc-1565	2	43	1	1	NUM
dpc-1565	2	44	dermatology	dermatology	NOUN
dpc-1565	2	45	department	department	NOUN
dpc-1565	2	46	,	,	PUNCT
dpc-1565	2	47	shahid	shahid	PROPN
dpc-1565	2	48	faghihi	faghihi	PROPN
dpc-1565	2	49	hospital	hospital	PROPN
dpc-1565	2	50	,	,	PUNCT
dpc-1565	2	51	shiraz	shiraz	PROPN
dpc-1565	2	52	university	university	PROPN
dpc-1565	2	53	of	of	ADP
dpc-1565	2	54	medical	medical	ADJ
dpc-1565	2	55	sciences	sciences	PROPN
dpc-1565	2	56	,	,	PUNCT
dpc-1565	2	57	shiraz	shiraz	PROPN
dpc-1565	2	58	,	,	PUNCT
dpc-1565	2	59	iran	iran	PROPN
dpc-1565	2	60	2	2	NUM
dpc-1565	2	61	student	student	NOUN
dpc-1565	2	62	research	research	NOUN
dpc-1565	2	63	committee	committee	NOUN
dpc-1565	2	64	,	,	PUNCT
dpc-1565	2	65	shiraz	shiraz	PROPN
dpc-1565	2	66	university	university	PROPN
dpc-1565	2	67	of	of	ADP
dpc-1565	2	68	medical	medical	ADJ
dpc-1565	2	69	sciences	sciences	PROPN
dpc-1565	2	70	,	,	PUNCT
dpc-1565	2	71	shiraz	shiraz	PROPN
dpc-1565	2	72	,	,	PUNCT
dpc-1565	2	73	iran	iran	PROPN
dpc-1565	2	74	key	key	ADJ
dpc-1565	2	75	words	word	NOUN
dpc-1565	2	76	:	:	PUNCT
dpc-1565	2	77	topical	topical	ADJ
dpc-1565	2	78	,	,	PUNCT
dpc-1565	2	79	sodium	sodium	NOUN
dpc-1565	2	80	hypochlorite	hypochlorite	NOUN
dpc-1565	2	81	,	,	PUNCT
dpc-1565	2	82	acne	acne	NOUN
dpc-1565	2	83	vulgaris	vulgaris	NOUN
dpc-1565	2	84	,	,	PUNCT
dpc-1565	2	85	treatment	treatment	NOUN
dpc-1565	2	86	citation	citation	NOUN
dpc-1565	2	87	:	:	PUNCT
dpc-1565	3	1	dorostkar	dorostkar	PROPN
dpc-1565	3	2	a	a	PROPN
dpc-1565	3	3	,	,	PUNCT
dpc-1565	3	4	ghahartars	ghahartars	PROPN
dpc-1565	3	5	m	m	PROPN
dpc-1565	3	6	,	,	PUNCT
dpc-1565	3	7	namazi	namazi	PROPN
dpc-1565	3	8	mr	mr	PROPN
dpc-1565	3	9	,	,	PUNCT
dpc-1565	3	10	todarbary	todarbary	ADJ
dpc-1565	3	11	n	n	CCONJ
dpc-1565	3	12	,	,	PUNCT
dpc-1565	3	13	hadibarhaghtalab	hadibarhaghtalab	PROPN
dpc-1565	3	14	m	m	PROPN
dpc-1565	3	15	,	,	PUNCT
dpc-1565	3	16	rezaee	rezaee	PROPN
dpc-1565	3	17	m.	m.	PROPN
dpc-1565	3	18	sodium	sodium	PROPN
dpc-1565	3	19	hypochlorite	hypochlorite	NOUN
dpc-1565	3	20	0.005	0.005	NUM
dpc-1565	3	21	%	%	NOUN
dpc-1565	3	22	versus	versus	ADP
dpc-1565	3	23	placebo	placebo	NOUN
dpc-1565	3	24	in	in	ADP
dpc-1565	3	25	the	the	DET
dpc-1565	3	26	treatment	treatment	NOUN
dpc-1565	3	27	of	of	ADP
dpc-1565	3	28	mild	mild	ADJ
dpc-1565	3	29	to	to	ADP
dpc-1565	3	30	moderate	moderate	ADJ
dpc-1565	3	31	acne	acne	NOUN
dpc-1565	3	32	:	:	PUNCT
dpc-1565	3	33	a	a	DET
dpc-1565	3	34	double	double	ADJ
dpc-1565	3	35	-	-	PUNCT
dpc-1565	3	36	blind	blind	ADJ
dpc-1565	3	37	randomized	randomize	VERB
dpc-1565	3	38	controlled	control	VERB
dpc-1565	3	39	trial	trial	NOUN
dpc-1565	3	40	.	.	PUNCT
dpc-1565	4	1	dermatol	dermatol	NOUN
dpc-1565	4	2	pract	pract	PROPN
dpc-1565	4	3	concept	concept	NOUN
dpc-1565	4	4	.	.	PUNCT
dpc-1565	5	1	2021;11(3):e2021046	2021;11(3):e2021046	X
dpc-1565	5	2	.	.	PUNCT
dpc-1565	6	1	doi	doi	NOUN
dpc-1565	6	2	:	:	PUNCT
dpc-1565	6	3	https://doi.org/10.5826/dpc.1103a46	https://doi.org/10.5826/dpc.1103a46	PROPN
dpc-1565	6	4	accepted	accept	VERB
dpc-1565	6	5	:	:	PUNCT
dpc-1565	6	6	december	december	PROPN
dpc-1565	6	7	9	9	NUM
dpc-1565	6	8	,	,	PUNCT
dpc-1565	6	9	2020	2020	NUM
dpc-1565	6	10	;	;	PUNCT
dpc-1565	6	11	published	publish	VERB
dpc-1565	6	12	:	:	PUNCT
dpc-1565	6	13	may	may	AUX
dpc-1565	6	14	20	20	NUM
dpc-1565	6	15	,	,	PUNCT
dpc-1565	6	16	2021	2021	NUM
dpc-1565	6	17	copyright	copyright	NOUN
dpc-1565	6	18	:	:	PUNCT
dpc-1565	7	1	©	©	PROPN
dpc-1565	7	2	2021	2021	NUM
dpc-1565	7	3	dorostkar	dorostkar	NOUN
dpc-1565	7	4	et	et	PROPN
dpc-1565	7	5	al	al	PROPN
dpc-1565	7	6	.	.	PUNCT
dpc-1565	8	1	this	this	PRON
dpc-1565	8	2	is	be	AUX
dpc-1565	8	3	an	an	DET
dpc-1565	8	4	open	open	ADJ
dpc-1565	8	5	-	-	PUNCT
dpc-1565	8	6	access	access	NOUN
dpc-1565	8	7	article	article	NOUN
dpc-1565	8	8	distributed	distribute	VERB
dpc-1565	8	9	under	under	ADP
dpc-1565	8	10	the	the	DET
dpc-1565	8	11	terms	term	NOUN
dpc-1565	8	12	of	of	ADP
dpc-1565	8	13	the	the	DET
dpc-1565	8	14	creative	creative	ADJ
dpc-1565	8	15	commons	common	NOUN
dpc-1565	8	16	attribution	attribution	NOUN
dpc-1565	8	17	license	license	NOUN
dpc-1565	8	18	by	by	ADP
dpc-1565	8	19	-	-	PUNCT
dpc-1565	8	20	nc-4.0	nc-4.0	NOUN
dpc-1565	8	21	,	,	PUNCT
dpc-1565	8	22	which	which	PRON
dpc-1565	8	23	permits	permit	VERB
dpc-1565	8	24	unrestricted	unrestricted	ADJ
dpc-1565	8	25	noncommercial	noncommercial	ADJ
dpc-1565	8	26	use	use	NOUN
dpc-1565	8	27	,	,	PUNCT
dpc-1565	8	28	distribution	distribution	NOUN
dpc-1565	8	29	,	,	PUNCT
dpc-1565	8	30	and	and	CCONJ
dpc-1565	8	31	reproduction	reproduction	NOUN
dpc-1565	8	32	in	in	ADP
dpc-1565	8	33	any	any	DET
dpc-1565	8	34	medium	medium	NOUN
dpc-1565	8	35	,	,	PUNCT
dpc-1565	8	36	provided	provide	VERB
dpc-1565	8	37	the	the	DET
dpc-1565	8	38	original	original	ADJ
dpc-1565	8	39	authors	author	NOUN
dpc-1565	8	40	and	and	CCONJ
dpc-1565	8	41	source	source	NOUN
dpc-1565	8	42	are	be	AUX
dpc-1565	8	43	credited	credit	VERB
dpc-1565	8	44	.	.	PUNCT
dpc-1565	9	1	competing	compete	VERB
dpc-1565	9	2	interests	interest	NOUN
dpc-1565	9	3	:	:	PUNCT
dpc-1565	9	4	the	the	DET
dpc-1565	9	5	authors	author	NOUN
dpc-1565	9	6	have	have	VERB
dpc-1565	9	7	no	no	DET
dpc-1565	9	8	conflicts	conflict	NOUN
dpc-1565	9	9	of	of	ADP
dpc-1565	9	10	interest	interest	NOUN
dpc-1565	9	11	to	to	PART
dpc-1565	9	12	declare	declare	VERB
dpc-1565	9	13	.	.	PUNCT
dpc-1565	10	1	funding	funding	NOUN
dpc-1565	10	2	:	:	PUNCT
dpc-1565	10	3	none	none	NOUN
dpc-1565	10	4	corresponding	correspond	VERB
dpc-1565	10	5	author	author	NOUN
dpc-1565	10	6	:	:	PUNCT
dpc-1565	10	7	maryam	maryam	PROPN
dpc-1565	10	8	hadibarhaghtalab	hadibarhaghtalab	PROPN
dpc-1565	10	9	,	,	PUNCT
dpc-1565	10	10	department	department	NOUN
dpc-1565	10	11	of	of	ADP
dpc-1565	10	12	dermatology	dermatology	NOUN
dpc-1565	10	13	,	,	PUNCT
dpc-1565	10	14	faghihi	faghihi	PROPN
dpc-1565	10	15	hospital	hospital	PROPN
dpc-1565	10	16	,	,	PUNCT
dpc-1565	10	17	zand	zand	PROPN
dpc-1565	10	18	street	street	PROPN
dpc-1565	10	19	,	,	PUNCT
dpc-1565	10	20	shiraz	shiraz	PROPN
dpc-1565	10	21	,	,	PUNCT
dpc-1565	10	22	iran	iran	PROPN
dpc-1565	10	23	.	.	PUNCT
dpc-1565	11	1	email	email	NOUN
dpc-1565	11	2	:	:	PUNCT
dpc-1565	11	3	maryam_hadibarhaghtalab@yahoo.com	maryam_hadibarhaghtalab@yahoo.com	X
dpc-1565	11	4	background	background	NOUN
dpc-1565	11	5	:	:	PUNCT
dpc-1565	11	6	acne	acne	NOUN
dpc-1565	11	7	vulgaris	vulgaris	NOUN
dpc-1565	11	8	is	be	AUX
dpc-1565	11	9	a	a	DET
dpc-1565	11	10	common	common	ADJ
dpc-1565	11	11	inflammatory	inflammatory	ADJ
dpc-1565	11	12	disease	disease	NOUN
dpc-1565	11	13	of	of	ADP
dpc-1565	11	14	the	the	DET
dpc-1565	11	15	pilosebaceous	pilosebaceous	ADJ
dpc-1565	11	16	follicle	follicle	NOUN
dpc-1565	11	17	that	that	PRON
dpc-1565	11	18	affects	affect	VERB
dpc-1565	11	19	many	many	ADJ
dpc-1565	11	20	teenagers	teenager	NOUN
dpc-1565	11	21	and	and	CCONJ
dpc-1565	11	22	young	young	ADJ
dpc-1565	11	23	people	people	NOUN
dpc-1565	11	24	.	.	PUNCT
dpc-1565	12	1	there	there	PRON
dpc-1565	12	2	is	be	VERB
dpc-1565	12	3	an	an	DET
dpc-1565	12	4	obvious	obvious	ADJ
dpc-1565	12	5	need	need	NOUN
dpc-1565	12	6	for	for	ADP
dpc-1565	12	7	topical	topical	ADJ
dpc-1565	12	8	treatments	treatment	NOUN
dpc-1565	12	9	with	with	ADP
dpc-1565	12	10	good	good	ADJ
dpc-1565	12	11	tolerability	tolerability	NOUN
dpc-1565	12	12	and	and	CCONJ
dpc-1565	12	13	efficacy	efficacy	NOUN
dpc-1565	12	14	for	for	ADP
dpc-1565	12	15	the	the	DET
dpc-1565	12	16	management	management	NOUN
dpc-1565	12	17	of	of	ADP
dpc-1565	12	18	acne	acne	NOUN
dpc-1565	12	19	lesions	lesion	NOUN
dpc-1565	12	20	.	.	PUNCT
dpc-1565	13	1	objective	objective	NOUN
dpc-1565	13	2	:	:	PUNCT
dpc-1565	13	3	this	this	DET
dpc-1565	13	4	study	study	NOUN
dpc-1565	13	5	determined	determine	VERB
dpc-1565	13	6	the	the	DET
dpc-1565	13	7	therapeutic	therapeutic	ADJ
dpc-1565	13	8	efficacy	efficacy	NOUN
dpc-1565	13	9	of	of	ADP
dpc-1565	13	10	topical	topical	ADJ
dpc-1565	13	11	sodium	sodium	NOUN
dpc-1565	13	12	hypochlorite	hypochlorite	NOUN
dpc-1565	13	13	solution	solution	NOUN
dpc-1565	13	14	(	(	PUNCT
dpc-1565	13	15	0.005	0.005	NUM
dpc-1565	13	16	%	%	NOUN
dpc-1565	13	17	)	)	PUNCT
dpc-1565	13	18	in	in	ADP
dpc-1565	13	19	the	the	DET
dpc-1565	13	20	treatment	treatment	NOUN
dpc-1565	13	21	of	of	ADP
dpc-1565	13	22	mild	mild	ADJ
dpc-1565	13	23	to	to	ADP
dpc-1565	13	24	moderate	moderate	ADJ
dpc-1565	13	25	acne	acne	NOUN
dpc-1565	13	26	lesions	lesion	NOUN
dpc-1565	13	27	.	.	PUNCT
dpc-1565	14	1	methods	method	NOUN
dpc-1565	14	2	:	:	PUNCT
dpc-1565	14	3	this	this	DET
dpc-1565	14	4	placebo	placebo	NOUN
dpc-1565	14	5	-	-	PUNCT
dpc-1565	14	6	controlled	control	VERB
dpc-1565	14	7	randomized	randomize	VERB
dpc-1565	14	8	controlled	control	VERB
dpc-1565	14	9	trial	trial	NOUN
dpc-1565	14	10	compared	compare	VERB
dpc-1565	14	11	0.005	0.005	NUM
dpc-1565	14	12	%	%	NOUN
dpc-1565	14	13	sodium	sodium	NOUN
dpc-1565	14	14	hypochlorite	hypochlorite	NOUN
dpc-1565	14	15	to	to	ADP
dpc-1565	14	16	placebo	placebo	NOUN
dpc-1565	14	17	administered	administer	VERB
dpc-1565	14	18	topically	topically	ADV
dpc-1565	14	19	on	on	ADP
dpc-1565	14	20	each	each	DET
dpc-1565	14	21	side	side	NOUN
dpc-1565	14	22	of	of	ADP
dpc-1565	14	23	the	the	DET
dpc-1565	14	24	patients	patient	NOUN
dpc-1565	14	25	’	'	PUNCT
dpc-1565	14	26	faces	face	VERB
dpc-1565	14	27	3	3	NUM
dpc-1565	14	28	times	time	NOUN
dpc-1565	14	29	a	a	DET
dpc-1565	14	30	day	day	NOUN
dpc-1565	14	31	for	for	ADP
dpc-1565	14	32	1	1	NUM
dpc-1565	14	33	month	month	NOUN
dpc-1565	14	34	.	.	PUNCT
dpc-1565	15	1	the	the	DET
dpc-1565	15	2	numbers	number	NOUN
dpc-1565	15	3	of	of	ADP
dpc-1565	15	4	papules	papule	NOUN
dpc-1565	15	5	and	and	CCONJ
dpc-1565	15	6	pustules	pustule	NOUN
dpc-1565	15	7	were	be	AUX
dpc-1565	15	8	recorded	record	VERB
dpc-1565	15	9	at	at	ADP
dpc-1565	15	10	baseline	baseline	NOUN
dpc-1565	15	11	,	,	PUNCT
dpc-1565	15	12	1	1	NUM
dpc-1565	15	13	,	,	PUNCT
dpc-1565	15	14	2	2	NUM
dpc-1565	15	15	and	and	CCONJ
dpc-1565	15	16	4	4	NUM
dpc-1565	15	17	weeks	week	NOUN
dpc-1565	15	18	after	after	ADP
dpc-1565	15	19	initiation	initiation	NOUN
dpc-1565	15	20	.	.	PUNCT
dpc-1565	16	1	results	result	NOUN
dpc-1565	16	2	:	:	PUNCT
dpc-1565	16	3	the	the	DET
dpc-1565	16	4	total	total	ADJ
dpc-1565	16	5	number	number	NOUN
dpc-1565	16	6	of	of	ADP
dpc-1565	16	7	papules	papule	NOUN
dpc-1565	16	8	and	and	CCONJ
dpc-1565	16	9	pustules	pustule	NOUN
dpc-1565	16	10	decreased	decrease	VERB
dpc-1565	16	11	after	after	ADP
dpc-1565	16	12	topical	topical	ADJ
dpc-1565	16	13	application	application	NOUN
dpc-1565	16	14	of	of	ADP
dpc-1565	16	15	sodium	sodium	NOUN
dpc-1565	16	16	hypochlorite	hypochlorite	NOUN
dpc-1565	16	17	0.005	0.005	NUM
dpc-1565	16	18	%	%	NOUN
dpc-1565	16	19	for	for	ADP
dpc-1565	16	20	1	1	NUM
dpc-1565	16	21	month	month	NOUN
dpc-1565	16	22	.	.	PUNCT
dpc-1565	17	1	conclusions	conclusion	NOUN
dpc-1565	17	2	:	:	PUNCT
dpc-1565	17	3	topical	topical	ADJ
dpc-1565	17	4	sodium	sodium	NOUN
dpc-1565	17	5	hypochlorite	hypochlorite	NOUN
dpc-1565	17	6	solution	solution	NOUN
dpc-1565	17	7	(	(	PUNCT
dpc-1565	17	8	0.005	0.005	NUM
dpc-1565	17	9	%	%	NOUN
dpc-1565	17	10	)	)	PUNCT
dpc-1565	17	11	can	can	AUX
dpc-1565	17	12	be	be	AUX
dpc-1565	17	13	effective	effective	ADJ
dpc-1565	17	14	in	in	ADP
dpc-1565	17	15	the	the	DET
dpc-1565	17	16	treatment	treatment	NOUN
dpc-1565	17	17	of	of	ADP
dpc-1565	17	18	mild	mild	ADJ
dpc-1565	17	19	to	to	ADP
dpc-1565	17	20	moderate	moderate	ADJ
dpc-1565	17	21	acne	acne	NOUN
dpc-1565	17	22	,	,	PUNCT
dpc-1565	17	23	and	and	CCONJ
dpc-1565	17	24	its	its	PRON
dpc-1565	17	25	clinical	clinical	ADJ
dpc-1565	17	26	efficacy	efficacy	NOUN
dpc-1565	17	27	was	be	AUX
dpc-1565	17	28	evaluated	evaluate	VERB
dpc-1565	17	29	between	between	ADP
dpc-1565	17	30	the	the	DET
dpc-1565	17	31	male	male	ADJ
dpc-1565	17	32	and	and	CCONJ
dpc-1565	17	33	female	female	ADJ
dpc-1565	17	34	groups	group	NOUN
dpc-1565	17	35	and	and	CCONJ
dpc-1565	17	36	between	between	ADP
dpc-1565	17	37	the	the	DET
dpc-1565	17	38	hormonal	hormonal	ADJ
dpc-1565	17	39	and	and	CCONJ
dpc-1565	17	40	non	non	ADJ
dpc-1565	17	41	-	-	ADJ
dpc-1565	17	42	hormonal	hormonal	ADJ
dpc-1565	17	43	ones	one	NOUN
dpc-1565	17	44	.	.	PUNCT
dpc-1565	18	1	trial	trial	NOUN
dpc-1565	18	2	registration	registration	NOUN
dpc-1565	18	3	:	:	PUNCT
dpc-1565	18	4	our	our	PRON
dpc-1565	18	5	study	study	NOUN
dpc-1565	18	6	was	be	AUX
dpc-1565	18	7	registered	register	VERB
dpc-1565	18	8	in	in	ADP
dpc-1565	18	9	the	the	DET
dpc-1565	18	10	iranian	iranian	ADJ
dpc-1565	18	11	registry	registry	NOUN
dpc-1565	18	12	of	of	ADP
dpc-1565	18	13	clinical	clinical	ADJ
dpc-1565	18	14	trials	trial	NOUN
dpc-1565	18	15	(	(	PUNCT
dpc-1565	18	16	irct	irct	PROPN
dpc-1565	18	17	)	)	PUNCT
dpc-1565	18	18	with	with	ADP
dpc-1565	18	19	the	the	DET
dpc-1565	18	20	code	code	NOUN
dpc-1565	18	21	number	number	NOUN
dpc-1565	18	22	irct20200701047976n1	irct20200701047976n1	NOUN
dpc-1565	18	23	.	.	PUNCT
dpc-1565	19	1	abstract	abstract	ADJ
dpc-1565	19	2	2	2	NUM
dpc-1565	19	3	research	research	NOUN
dpc-1565	19	4	|	|	ADV
dpc-1565	19	5	dermatol	dermatol	ADJ
dpc-1565	19	6	pract	pract	NOUN
dpc-1565	19	7	concept	concept	NOUN
dpc-1565	19	8	.	.	PUNCT
dpc-1565	20	1	2021;11(3):e2021046	2021;11(3):e2021046	CCONJ
dpc-1565	20	2	introduction	introduction	NOUN
dpc-1565	20	3	acne	acne	NOUN
dpc-1565	20	4	vulgaris	vulgaris	NOUN
dpc-1565	20	5	,	,	PUNCT
dpc-1565	20	6	the	the	DET
dpc-1565	20	7	most	most	ADV
dpc-1565	20	8	common	common	ADJ
dpc-1565	20	9	dermatological	dermatological	ADJ
dpc-1565	20	10	disease	disease	NOUN
dpc-1565	20	11	,	,	PUNCT
dpc-1565	20	12	affects	affect	VERB
dpc-1565	20	13	35%-90	35%-90	NUM
dpc-1565	20	14	%	%	NOUN
dpc-1565	20	15	of	of	ADP
dpc-1565	20	16	adolescents	adolescent	NOUN
dpc-1565	20	17	[	[	X
dpc-1565	20	18	1	1	NUM
dpc-1565	20	19	]	]	PUNCT
dpc-1565	20	20	.	.	PUNCT
dpc-1565	21	1	acne	acne	NOUN
dpc-1565	21	2	is	be	AUX
dpc-1565	21	3	inflammation	inflammation	NOUN
dpc-1565	21	4	of	of	ADP
dpc-1565	21	5	the	the	DET
dpc-1565	21	6	pilosebaceous	pilosebaceous	ADJ
dpc-1565	21	7	units	unit	NOUN
dpc-1565	21	8	of	of	ADP
dpc-1565	21	9	the	the	DET
dpc-1565	21	10	skin	skin	NOUN
dpc-1565	21	11	,	,	PUNCT
dpc-1565	21	12	and	and	CCONJ
dpc-1565	21	13	it	it	PRON
dpc-1565	21	14	presents	present	VERB
dpc-1565	21	15	as	as	ADP
dpc-1565	21	16	lesions	lesion	NOUN
dpc-1565	21	17	such	such	ADJ
dpc-1565	21	18	as	as	ADP
dpc-1565	21	19	scars	scar	NOUN
dpc-1565	21	20	and	and	CCONJ
dpc-1565	21	21	hyperpigmentation	hyperpigmentation	NOUN
dpc-1565	21	22	[	[	X
dpc-1565	21	23	2	2	NUM
dpc-1565	21	24	]	]	PUNCT
dpc-1565	21	25	.	.	PUNCT
dpc-1565	22	1	although	although	SCONJ
dpc-1565	22	2	the	the	DET
dpc-1565	22	3	ideal	ideal	ADJ
dpc-1565	22	4	treatment	treatment	NOUN
dpc-1565	22	5	for	for	ADP
dpc-1565	22	6	acne	acne	NOUN
dpc-1565	22	7	is	be	AUX
dpc-1565	22	8	still	still	ADV
dpc-1565	22	9	under	under	ADP
dpc-1565	22	10	investigation	investigation	NOUN
dpc-1565	22	11	,	,	PUNCT
dpc-1565	22	12	an	an	DET
dpc-1565	22	13	effective	effective	ADJ
dpc-1565	22	14	regimen	regiman	NOUN
dpc-1565	22	15	to	to	PART
dpc-1565	22	16	reduce	reduce	VERB
dpc-1565	22	17	lesions	lesion	NOUN
dpc-1565	22	18	can	can	AUX
dpc-1565	22	19	be	be	AUX
dpc-1565	22	20	found	find	VERB
dpc-1565	22	21	for	for	ADP
dpc-1565	22	22	most	most	ADJ
dpc-1565	22	23	patients	patient	NOUN
dpc-1565	22	24	.	.	PUNCT
dpc-1565	23	1	however	however	ADV
dpc-1565	23	2	,	,	PUNCT
dpc-1565	23	3	there	there	PRON
dpc-1565	23	4	is	be	VERB
dpc-1565	23	5	a	a	DET
dpc-1565	23	6	lack	lack	NOUN
dpc-1565	23	7	of	of	ADP
dpc-1565	23	8	high	high	ADJ
dpc-1565	23	9	-	-	PUNCT
dpc-1565	23	10	quality	quality	NOUN
dpc-1565	23	11	evidence	evidence	NOUN
dpc-1565	23	12	on	on	ADP
dpc-1565	23	13	the	the	DET
dpc-1565	23	14	comparative	comparative	ADJ
dpc-1565	23	15	effectiveness	effectiveness	NOUN
dpc-1565	23	16	of	of	ADP
dpc-1565	23	17	common	common	ADJ
dpc-1565	23	18	topical	topical	ADJ
dpc-1565	23	19	and	and	CCONJ
dpc-1565	23	20	systemic	systemic	ADJ
dpc-1565	23	21	acne	acne	NOUN
dpc-1565	23	22	treatments	treatment	NOUN
dpc-1565	23	23	[	[	X
dpc-1565	23	24	3	3	NUM
dpc-1565	23	25	]	]	PUNCT
dpc-1565	23	26	.	.	PUNCT
dpc-1565	24	1	additionally	additionally	ADV
dpc-1565	24	2	,	,	PUNCT
dpc-1565	24	3	the	the	DET
dpc-1565	24	4	complex	complex	ADJ
dpc-1565	24	5	combination	combination	NOUN
dpc-1565	24	6	treatment	treatment	NOUN
dpc-1565	24	7	regimens	regimen	NOUN
dpc-1565	24	8	that	that	PRON
dpc-1565	24	9	affect	affect	VERB
dpc-1565	24	10	different	different	ADJ
dpc-1565	24	11	aspects	aspect	NOUN
dpc-1565	24	12	of	of	ADP
dpc-1565	24	13	acne	acne	NOUN
dpc-1565	24	14	pathophysiology	pathophysiology	NOUN
dpc-1565	24	15	can	can	AUX
dpc-1565	24	16	lead	lead	VERB
dpc-1565	24	17	to	to	ADP
dpc-1565	24	18	poor	poor	ADJ
dpc-1565	24	19	treatment	treatment	NOUN
dpc-1565	24	20	adherence	adherence	NOUN
dpc-1565	24	21	and	and	CCONJ
dpc-1565	24	22	may	may	AUX
dpc-1565	24	23	decrease	decrease	VERB
dpc-1565	24	24	the	the	DET
dpc-1565	24	25	effectiveness	effectiveness	NOUN
dpc-1565	24	26	of	of	ADP
dpc-1565	24	27	the	the	DET
dpc-1565	24	28	treatment	treatment	NOUN
dpc-1565	24	29	[	[	X
dpc-1565	24	30	4	4	NUM
dpc-1565	24	31	]	]	PUNCT
dpc-1565	24	32	.	.	PUNCT
dpc-1565	25	1	sodium	sodium	NOUN
dpc-1565	25	2	hypochlorite	hypochlorite	NOUN
dpc-1565	25	3	is	be	AUX
dpc-1565	25	4	a	a	DET
dpc-1565	25	5	common	common	ADJ
dpc-1565	25	6	antiseptic	antiseptic	ADJ
dpc-1565	25	7	agent	agent	NOUN
dpc-1565	25	8	with	with	ADP
dpc-1565	25	9	a	a	DET
dpc-1565	25	10	broad	broad	ADJ
dpc-1565	25	11	application	application	NOUN
dpc-1565	25	12	in	in	ADP
dpc-1565	25	13	medicine	medicine	NOUN
dpc-1565	25	14	,	,	PUNCT
dpc-1565	25	15	including	include	VERB
dpc-1565	25	16	use	use	NOUN
dpc-1565	25	17	in	in	ADP
dpc-1565	25	18	bladder	bladder	NOUN
dpc-1565	25	19	and	and	CCONJ
dpc-1565	25	20	urethra	urethra	NOUN
dpc-1565	25	21	irrigation	irrigation	NOUN
dpc-1565	25	22	,	,	PUNCT
dpc-1565	25	23	control	control	NOUN
dpc-1565	25	24	of	of	ADP
dpc-1565	25	25	some	some	DET
dpc-1565	25	26	topical	topical	ADJ
dpc-1565	25	27	mycoses	mycose	NOUN
dpc-1565	25	28	,	,	PUNCT
dpc-1565	25	29	prophylaxis	prophylaxi	VERB
dpc-1565	25	30	against	against	ADP
dpc-1565	25	31	burn	burn	NOUN
dpc-1565	25	32	infections	infection	NOUN
dpc-1565	25	33	,	,	PUNCT
dpc-1565	25	34	and	and	CCONJ
dpc-1565	25	35	as	as	ADP
dpc-1565	25	36	an	an	DET
dpc-1565	25	37	irrigant	irrigant	NOUN
dpc-1565	25	38	in	in	ADP
dpc-1565	25	39	dental	dental	ADJ
dpc-1565	25	40	root	root	NOUN
dpc-1565	25	41	canal	canal	NOUN
dpc-1565	25	42	procedures	procedure	NOUN
dpc-1565	25	43	[	[	X
dpc-1565	25	44	5	5	NUM
dpc-1565	25	45	]	]	PUNCT
dpc-1565	25	46	.	.	PUNCT
dpc-1565	26	1	in	in	ADP
dpc-1565	26	2	2017	2017	NUM
dpc-1565	26	3	,	,	PUNCT
dpc-1565	26	4	eriksson	eriksson	PROPN
dpc-1565	26	5	and	and	CCONJ
dpc-1565	26	6	colleagues	colleague	NOUN
dpc-1565	26	7	revealed	reveal	VERB
dpc-1565	26	8	that	that	SCONJ
dpc-1565	26	9	sodium	sodium	NOUN
dpc-1565	26	10	hypochlorite	hypochlorite	NOUN
dpc-1565	26	11	0.004	0.004	NUM
dpc-1565	26	12	%	%	NOUN
dpc-1565	26	13	considerably	considerably	ADV
dpc-1565	26	14	decreased	decrease	VERB
dpc-1565	26	15	the	the	DET
dpc-1565	26	16	s.	s.	PROPN
dpc-1565	26	17	aureus	aureus	PROPN
dpc-1565	26	18	load	load	NOUN
dpc-1565	26	19	in	in	ADP
dpc-1565	26	20	atopic	atopic	NOUN
dpc-1565	26	21	dermatitis	dermatitis	NOUN
dpc-1565	26	22	lesions	lesion	NOUN
dpc-1565	26	23	[	[	X
dpc-1565	26	24	6	6	NUM
dpc-1565	26	25	]	]	PUNCT
dpc-1565	26	26	.	.	PUNCT
dpc-1565	27	1	additionally	additionally	ADV
dpc-1565	27	2	,	,	PUNCT
dpc-1565	27	3	hunter	hunter	NOUN
dpc-1565	27	4	revealed	reveal	VERB
dpc-1565	27	5	that	that	SCONJ
dpc-1565	27	6	sodium	sodium	NOUN
dpc-1565	27	7	hypochlorite	hypochlorite	NOUN
dpc-1565	27	8	accelerated	accelerate	VERB
dpc-1565	27	9	the	the	DET
dpc-1565	27	10	remission	remission	NOUN
dpc-1565	27	11	of	of	ADP
dpc-1565	27	12	herpes	herpe	NOUN
dpc-1565	27	13	simplex	simplex	NOUN
dpc-1565	27	14	lesions	lesion	NOUN
dpc-1565	27	15	[	[	X
dpc-1565	27	16	5	5	NUM
dpc-1565	27	17	]	]	PUNCT
dpc-1565	27	18	.	.	PUNCT
dpc-1565	28	1	we	we	PRON
dpc-1565	28	2	hypothesized	hypothesize	VERB
dpc-1565	28	3	that	that	SCONJ
dpc-1565	28	4	sodium	sodium	NOUN
dpc-1565	28	5	hypochlorite	hypochlorite	NOUN
dpc-1565	28	6	0.005	0.005	NUM
dpc-1565	28	7	%	%	NOUN
dpc-1565	28	8	is	be	AUX
dpc-1565	28	9	possibly	possibly	ADV
dpc-1565	28	10	effective	effective	ADJ
dpc-1565	28	11	in	in	ADP
dpc-1565	28	12	treating	treat	VERB
dpc-1565	28	13	mild	mild	ADJ
dpc-1565	28	14	to	to	ADP
dpc-1565	28	15	moderate	moderate	ADJ
dpc-1565	28	16	acne	acne	NOUN
dpc-1565	28	17	.	.	PUNCT
dpc-1565	29	1	therefore	therefore	ADV
dpc-1565	29	2	,	,	PUNCT
dpc-1565	29	3	this	this	DET
dpc-1565	29	4	placebo	placebo	NOUN
dpc-1565	29	5	-	-	PUNCT
dpc-1565	29	6	controlled	control	VERB
dpc-1565	29	7	,	,	PUNCT
dpc-1565	29	8	randomized	randomize	VERB
dpc-1565	29	9	controlled	control	VERB
dpc-1565	29	10	trial	trial	NOUN
dpc-1565	29	11	investigated	investigate	VERB
dpc-1565	29	12	the	the	DET
dpc-1565	29	13	therapeutic	therapeutic	ADJ
dpc-1565	29	14	efficacy	efficacy	NOUN
dpc-1565	29	15	of	of	ADP
dpc-1565	29	16	sodium	sodium	NOUN
dpc-1565	29	17	hypochlorite	hypochlorite	NOUN
dpc-1565	29	18	0.005	0.005	NUM
dpc-1565	29	19	%	%	NOUN
dpc-1565	29	20	in	in	ADP
dpc-1565	29	21	the	the	DET
dpc-1565	29	22	treatment	treatment	NOUN
dpc-1565	29	23	of	of	ADP
dpc-1565	29	24	mild	mild	ADJ
dpc-1565	29	25	to	to	ADP
dpc-1565	29	26	moderate	moderate	ADJ
dpc-1565	29	27	acne	acne	NOUN
dpc-1565	29	28	.	.	PUNCT
dpc-1565	30	1	methods	method	NOUN
dpc-1565	30	2	this	this	PRON
dpc-1565	30	3	randomized	randomize	VERB
dpc-1565	30	4	controlled	control	VERB
dpc-1565	30	5	trial	trial	NOUN
dpc-1565	30	6	was	be	AUX
dpc-1565	30	7	conducted	conduct	VERB
dpc-1565	30	8	on	on	ADP
dpc-1565	30	9	40	40	NUM
dpc-1565	30	10	consecutive	consecutive	ADJ
dpc-1565	30	11	acne	acne	NOUN
dpc-1565	30	12	patients	patient	NOUN
dpc-1565	30	13	seen	see	VERB
dpc-1565	30	14	at	at	ADP
dpc-1565	30	15	the	the	DET
dpc-1565	30	16	dermatology	dermatology	NOUN
dpc-1565	30	17	clinic	clinic	NOUN
dpc-1565	30	18	of	of	ADP
dpc-1565	30	19	shahid	shahid	PROPN
dpc-1565	30	20	faghihi	faghihi	PROPN
dpc-1565	30	21	hospital	hospital	PROPN
dpc-1565	30	22	,	,	PUNCT
dpc-1565	30	23	from	from	ADP
dpc-1565	30	24	november	november	PROPN
dpc-1565	30	25	2017	2017	NUM
dpc-1565	30	26	to	to	ADP
dpc-1565	30	27	april	april	PROPN
dpc-1565	30	28	2018	2018	NUM
dpc-1565	30	29	.	.	PUNCT
dpc-1565	31	1	patients	patient	NOUN
dpc-1565	31	2	with	with	ADP
dpc-1565	31	3	secondary	secondary	ADJ
dpc-1565	31	4	acne	acne	NOUN
dpc-1565	31	5	caused	cause	VERB
dpc-1565	31	6	by	by	ADP
dpc-1565	31	7	lactation	lactation	NOUN
dpc-1565	31	8	,	,	PUNCT
dpc-1565	31	9	dermatology	dermatology	NOUN
dpc-1565	31	10	conditions	condition	NOUN
dpc-1565	31	11	,	,	PUNCT
dpc-1565	31	12	or	or	CCONJ
dpc-1565	31	13	allergy	allergy	NOUN
dpc-1565	31	14	to	to	ADP
dpc-1565	31	15	sodium	sodium	NOUN
dpc-1565	31	16	hypochlorite	hypochlorite	NOUN
dpc-1565	31	17	as	as	ADV
dpc-1565	31	18	well	well	ADV
dpc-1565	31	19	as	as	ADP
dpc-1565	31	20	those	those	PRON
dpc-1565	31	21	who	who	PRON
dpc-1565	31	22	had	have	AUX
dpc-1565	31	23	taken	take	VERB
dpc-1565	31	24	isotretinoin	isotretinoin	NOUN
dpc-1565	31	25	or	or	CCONJ
dpc-1565	31	26	systemic	systemic	ADJ
dpc-1565	31	27	or	or	CCONJ
dpc-1565	31	28	topical	topical	ADJ
dpc-1565	31	29	antibiotics	antibiotic	NOUN
dpc-1565	31	30	within	within	ADP
dpc-1565	31	31	the	the	DET
dpc-1565	31	32	past	past	ADJ
dpc-1565	31	33	2	2	NUM
dpc-1565	31	34	months	month	NOUN
dpc-1565	31	35	were	be	AUX
dpc-1565	31	36	excluded	exclude	VERB
dpc-1565	31	37	from	from	ADP
dpc-1565	31	38	the	the	DET
dpc-1565	31	39	study	study	NOUN
dpc-1565	31	40	.	.	PUNCT
dpc-1565	32	1	the	the	DET
dpc-1565	32	2	review	review	PROPN
dpc-1565	32	3	board	board	NOUN
dpc-1565	32	4	of	of	ADP
dpc-1565	32	5	shiraz	shiraz	PROPN
dpc-1565	32	6	university	university	PROPN
dpc-1565	32	7	of	of	ADP
dpc-1565	32	8	medical	medical	PROPN
dpc-1565	32	9	sciences	sciences	PROPN
dpc-1565	32	10	approved	approve	VERB
dpc-1565	32	11	the	the	DET
dpc-1565	32	12	study	study	NOUN
dpc-1565	32	13	,	,	PUNCT
dpc-1565	32	14	and	and	CCONJ
dpc-1565	32	15	all	all	DET
dpc-1565	32	16	recruited	recruit	VERB
dpc-1565	32	17	patients	patient	NOUN
dpc-1565	32	18	filled	fill	VERB
dpc-1565	32	19	the	the	DET
dpc-1565	32	20	informed	informed	ADJ
dpc-1565	32	21	consent	consent	NOUN
dpc-1565	32	22	form	form	NOUN
dpc-1565	32	23	.	.	PUNCT
dpc-1565	33	1	the	the	DET
dpc-1565	33	2	study	study	NOUN
dpc-1565	33	3	was	be	AUX
dpc-1565	33	4	registered	register	VERB
dpc-1565	33	5	in	in	ADP
dpc-1565	33	6	the	the	DET
dpc-1565	33	7	iranian	iranian	ADJ
dpc-1565	33	8	registry	registry	NOUN
dpc-1565	33	9	of	of	ADP
dpc-1565	33	10	clinical	clinical	ADJ
dpc-1565	33	11	trials	trial	NOUN
dpc-1565	33	12	(	(	PUNCT
dpc-1565	33	13	irct	irct	PROPN
dpc-1565	33	14	)	)	PUNCT
dpc-1565	33	15	with	with	ADP
dpc-1565	33	16	the	the	DET
dpc-1565	33	17	code	code	NOUN
dpc-1565	33	18	number	number	NOUN
dpc-1565	33	19	irct20200701047976n1	irct20200701047976n1	PROPN
dpc-1565	33	20	.	.	PUNCT
dpc-1565	34	1	the	the	DET
dpc-1565	34	2	patients	patient	NOUN
dpc-1565	34	3	were	be	AUX
dpc-1565	34	4	randomly	randomly	ADV
dpc-1565	34	5	assigned	assign	VERB
dpc-1565	34	6	to	to	PART
dpc-1565	34	7	receive	receive	VERB
dpc-1565	34	8	sodium	sodium	NOUN
dpc-1565	34	9	hypochlorite	hypochlorite	NOUN
dpc-1565	34	10	0.005	0.005	NUM
dpc-1565	34	11	%	%	NOUN
dpc-1565	34	12	or	or	CCONJ
dpc-1565	34	13	placebo	placebo	NOUN
dpc-1565	34	14	,	,	PUNCT
dpc-1565	34	15	to	to	PART
dpc-1565	34	16	be	be	AUX
dpc-1565	34	17	administered	administer	VERB
dpc-1565	34	18	topically	topically	ADV
dpc-1565	34	19	on	on	ADP
dpc-1565	34	20	each	each	DET
dpc-1565	34	21	side	side	NOUN
dpc-1565	34	22	of	of	ADP
dpc-1565	34	23	their	their	PRON
dpc-1565	34	24	face	face	NOUN
dpc-1565	34	25	3	3	NUM
dpc-1565	34	26	times	time	NOUN
dpc-1565	34	27	a	a	DET
dpc-1565	34	28	day	day	NOUN
dpc-1565	34	29	for	for	ADP
dpc-1565	34	30	1	1	NUM
dpc-1565	34	31	month	month	NOUN
dpc-1565	34	32	.	.	PUNCT
dpc-1565	35	1	the	the	DET
dpc-1565	35	2	patients	patient	NOUN
dpc-1565	35	3	were	be	AUX
dpc-1565	35	4	not	not	PART
dpc-1565	35	5	aware	aware	ADJ
dpc-1565	35	6	of	of	ADP
dpc-1565	35	7	the	the	DET
dpc-1565	35	8	type	type	NOUN
dpc-1565	35	9	of	of	ADP
dpc-1565	35	10	solution	solution	NOUN
dpc-1565	35	11	(	(	PUNCT
dpc-1565	35	12	placebo	placebo	NOUN
dpc-1565	35	13	or	or	CCONJ
dpc-1565	35	14	sodium	sodium	NOUN
dpc-1565	35	15	hypochlorite	hypochlorite	NOUN
dpc-1565	35	16	)	)	PUNCT
dpc-1565	35	17	applied	apply	VERB
dpc-1565	35	18	to	to	ADP
dpc-1565	35	19	their	their	PRON
dpc-1565	35	20	faces	face	NOUN
dpc-1565	35	21	.	.	PUNCT
dpc-1565	36	1	moreover	moreover	ADV
dpc-1565	36	2	,	,	PUNCT
dpc-1565	36	3	the	the	DET
dpc-1565	36	4	dermatologist	dermatologist	NOUN
dpc-1565	36	5	and	and	CCONJ
dpc-1565	36	6	the	the	DET
dpc-1565	36	7	observer	observer	NOUN
dpc-1565	36	8	were	be	AUX
dpc-1565	36	9	blinded	blind	VERB
dpc-1565	36	10	to	to	ADP
dpc-1565	36	11	the	the	DET
dpc-1565	36	12	identity	identity	NOUN
dpc-1565	36	13	of	of	ADP
dpc-1565	36	14	the	the	DET
dpc-1565	36	15	solution	solution	NOUN
dpc-1565	36	16	applied	apply	VERB
dpc-1565	36	17	to	to	ADP
dpc-1565	36	18	each	each	DET
dpc-1565	36	19	patient	patient	NOUN
dpc-1565	36	20	.	.	PUNCT
dpc-1565	37	1	we	we	PRON
dpc-1565	37	2	used	use	VERB
dpc-1565	37	3	the	the	DET
dpc-1565	37	4	modified	modify	VERB
dpc-1565	37	5	global	global	ADJ
dpc-1565	37	6	acne	acne	NOUN
dpc-1565	37	7	grading	grade	VERB
dpc-1565	37	8	scale	scale	NOUN
dpc-1565	37	9	(	(	PUNCT
dpc-1565	37	10	mgags	mgag	NOUN
dpc-1565	37	11	)	)	PUNCT
dpc-1565	37	12	to	to	PART
dpc-1565	37	13	assess	assess	VERB
dpc-1565	37	14	the	the	DET
dpc-1565	37	15	severity	severity	NOUN
dpc-1565	37	16	of	of	ADP
dpc-1565	37	17	acne	acne	NOUN
dpc-1565	37	18	during	during	ADP
dpc-1565	37	19	the	the	DET
dpc-1565	37	20	study	study	NOUN
dpc-1565	37	21	.	.	PUNCT
dpc-1565	38	1	statistical	statistical	ADJ
dpc-1565	38	2	package	package	NOUN
dpc-1565	38	3	for	for	ADP
dpc-1565	38	4	social	social	ADJ
dpc-1565	38	5	science	science	NOUN
dpc-1565	38	6	for	for	ADP
dpc-1565	38	7	windows	window	NOUN
dpc-1565	38	8	was	be	AUX
dpc-1565	38	9	used	use	VERB
dpc-1565	38	10	for	for	ADP
dpc-1565	38	11	data	datum	NOUN
dpc-1565	38	12	analysis	analysis	NOUN
dpc-1565	38	13	.	.	PUNCT
dpc-1565	39	1	because	because	SCONJ
dpc-1565	39	2	the	the	DET
dpc-1565	39	3	data	datum	NOUN
dpc-1565	39	4	were	be	AUX
dpc-1565	39	5	non	non	ADJ
dpc-1565	39	6	-	-	ADJ
dpc-1565	39	7	parametric	parametric	ADJ
dpc-1565	39	8	,	,	PUNCT
dpc-1565	39	9	we	we	PRON
dpc-1565	39	10	used	use	VERB
dpc-1565	39	11	the	the	DET
dpc-1565	39	12	wilcoxon	wilcoxon	ADJ
dpc-1565	39	13	test	test	NOUN
dpc-1565	39	14	to	to	PART
dpc-1565	39	15	compare	compare	VERB
dpc-1565	39	16	the	the	DET
dpc-1565	39	17	numbers	number	NOUN
dpc-1565	39	18	of	of	ADP
dpc-1565	39	19	lesions	lesion	NOUN
dpc-1565	39	20	between	between	ADP
dpc-1565	39	21	the	the	DET
dpc-1565	39	22	two	two	NUM
dpc-1565	39	23	groups	group	NOUN
dpc-1565	39	24	.	.	PUNCT
dpc-1565	40	1	additionally	additionally	ADV
dpc-1565	40	2	,	,	PUNCT
dpc-1565	40	3	we	we	PRON
dpc-1565	40	4	used	use	VERB
dpc-1565	40	5	the	the	DET
dpc-1565	40	6	friedman	friedman	PROPN
dpc-1565	40	7	test	test	NOUN
dpc-1565	40	8	to	to	PART
dpc-1565	40	9	evaluate	evaluate	VERB
dpc-1565	40	10	changes	change	NOUN
dpc-1565	40	11	in	in	ADP
dpc-1565	40	12	the	the	DET
dpc-1565	40	13	number	number	NOUN
dpc-1565	40	14	of	of	ADP
dpc-1565	40	15	papules	papule	NOUN
dpc-1565	40	16	and	and	CCONJ
dpc-1565	40	17	pustules	pustule	NOUN
dpc-1565	40	18	during	during	ADP
dpc-1565	40	19	the	the	DET
dpc-1565	40	20	study	study	NOUN
dpc-1565	40	21	.	.	PUNCT
dpc-1565	41	1	a	a	PRON
dpc-1565	41	2	p	p	NOUN
dpc-1565	41	3	-	-	PUNCT
dpc-1565	41	4	value	value	NOUN
dpc-1565	41	5	<	<	NOUN
dpc-1565	41	6	0.05	0.05	NUM
dpc-1565	41	7	was	be	AUX
dpc-1565	41	8	considered	consider	VERB
dpc-1565	41	9	statistically	statistically	ADV
dpc-1565	41	10	significant	significant	ADJ
dpc-1565	41	11	.	.	PUNCT
dpc-1565	42	1	results	result	VERB
dpc-1565	42	2	the	the	DET
dpc-1565	42	3	study	study	NOUN
dpc-1565	42	4	enrolled	enrol	VERB
dpc-1565	42	5	40	40	NUM
dpc-1565	42	6	patients	patient	NOUN
dpc-1565	42	7	with	with	ADP
dpc-1565	42	8	mild	mild	ADJ
dpc-1565	42	9	to	to	ADP
dpc-1565	42	10	moderate	moderate	ADJ
dpc-1565	42	11	acne	acne	NOUN
dpc-1565	42	12	,	,	PUNCT
dpc-1565	42	13	including	include	VERB
dpc-1565	42	14	32	32	NUM
dpc-1565	42	15	(	(	PUNCT
dpc-1565	42	16	80	80	NUM
dpc-1565	42	17	%	%	NOUN
dpc-1565	42	18	)	)	PUNCT
dpc-1565	42	19	women	woman	NOUN
dpc-1565	42	20	and	and	CCONJ
dpc-1565	42	21	8	8	NUM
dpc-1565	42	22	(	(	PUNCT
dpc-1565	42	23	20	20	NUM
dpc-1565	42	24	%	%	NOUN
dpc-1565	42	25	)	)	PUNCT
dpc-1565	42	26	men	man	NOUN
dpc-1565	42	27	.	.	PUNCT
dpc-1565	43	1	the	the	DET
dpc-1565	43	2	mean	mean	ADJ
dpc-1565	43	3	age	age	NOUN
dpc-1565	43	4	of	of	ADP
dpc-1565	43	5	the	the	DET
dpc-1565	43	6	patients	patient	NOUN
dpc-1565	43	7	was	be	AUX
dpc-1565	43	8	21.3	21.3	NUM
dpc-1565	43	9	years	year	NOUN
dpc-1565	43	10	(	(	PUNCT
dpc-1565	43	11	range	range	NOUN
dpc-1565	43	12	,	,	PUNCT
dpc-1565	43	13	15–28	15–28	NUM
dpc-1565	43	14	years	year	NOUN
dpc-1565	43	15	)	)	PUNCT
dpc-1565	43	16	.	.	PUNCT
dpc-1565	44	1	after	after	ADP
dpc-1565	44	2	one	one	NUM
dpc-1565	44	3	month	month	NOUN
dpc-1565	44	4	,	,	PUNCT
dpc-1565	44	5	the	the	DET
dpc-1565	44	6	total	total	ADJ
dpc-1565	44	7	number	number	NOUN
dpc-1565	44	8	of	of	ADP
dpc-1565	44	9	papules	papule	NOUN
dpc-1565	44	10	and	and	CCONJ
dpc-1565	44	11	pustules	pustule	NOUN
dpc-1565	44	12	decreased	decrease	VERB
dpc-1565	44	13	significantly	significantly	ADV
dpc-1565	44	14	,	,	PUNCT
dpc-1565	44	15	from	from	ADP
dpc-1565	44	16	759	759	NUM
dpc-1565	44	17	to	to	ADP
dpc-1565	44	18	476	476	NUM
dpc-1565	44	19	,	,	PUNCT
dpc-1565	44	20	in	in	ADP
dpc-1565	44	21	the	the	DET
dpc-1565	44	22	patients	patient	NOUN
dpc-1565	44	23	(	(	PUNCT
dpc-1565	44	24	p	p	X
dpc-1565	44	25	<	<	X
dpc-1565	44	26	0.0001	0.0001	NUM
dpc-1565	44	27	)	)	PUNCT
dpc-1565	44	28	.	.	PUNCT
dpc-1565	45	1	moreover	moreover	ADV
dpc-1565	45	2	,	,	PUNCT
dpc-1565	45	3	the	the	DET
dpc-1565	45	4	number	number	NOUN
dpc-1565	45	5	of	of	ADP
dpc-1565	45	6	papules	papule	NOUN
dpc-1565	45	7	decreased	decrease	VERB
dpc-1565	45	8	significantly	significantly	ADV
dpc-1565	45	9	after	after	ADP
dpc-1565	45	10	one	one	NUM
dpc-1565	45	11	month	month	NOUN
dpc-1565	45	12	(	(	PUNCT
dpc-1565	45	13	p	p	X
dpc-1565	45	14	<	<	X
dpc-1565	45	15	0.0001	0.0001	NUM
dpc-1565	45	16	)	)	PUNCT
dpc-1565	45	17	,	,	PUNCT
dpc-1565	45	18	while	while	SCONJ
dpc-1565	45	19	the	the	DET
dpc-1565	45	20	number	number	NOUN
dpc-1565	45	21	of	of	ADP
dpc-1565	45	22	pustules	pustule	NOUN
dpc-1565	45	23	did	do	AUX
dpc-1565	45	24	not	not	PART
dpc-1565	45	25	change	change	VERB
dpc-1565	45	26	significantly	significantly	ADV
dpc-1565	45	27	(	(	PUNCT
dpc-1565	45	28	p	p	X
dpc-1565	45	29	=	=	NOUN
dpc-1565	45	30	0.692	0.692	NUM
dpc-1565	45	31	)	)	PUNCT
dpc-1565	45	32	.	.	PUNCT
dpc-1565	46	1	table	table	NOUN
dpc-1565	46	2	1	1	NUM
dpc-1565	46	3	shows	show	VERB
dpc-1565	46	4	the	the	DET
dpc-1565	46	5	statistical	statistical	ADJ
dpc-1565	46	6	analysis	analysis	NOUN
dpc-1565	46	7	of	of	ADP
dpc-1565	46	8	papules	papule	NOUN
dpc-1565	46	9	and	and	CCONJ
dpc-1565	46	10	pustules	pustule	NOUN
dpc-1565	46	11	over	over	ADP
dpc-1565	46	12	1	1	NUM
dpc-1565	46	13	month	month	NOUN
dpc-1565	46	14	.	.	PUNCT
dpc-1565	47	1	table	table	NOUN
dpc-1565	47	2	2	2	NUM
dpc-1565	47	3	shows	show	VERB
dpc-1565	47	4	the	the	DET
dpc-1565	47	5	statistical	statistical	ADJ
dpc-1565	47	6	analysis	analysis	NOUN
dpc-1565	47	7	in	in	ADP
dpc-1565	47	8	hormonal	hormonal	ADJ
dpc-1565	47	9	and	and	CCONJ
dpc-1565	47	10	non	non	ADJ
dpc-1565	47	11	-	-	ADJ
dpc-1565	47	12	hormonal	hormonal	ADJ
dpc-1565	47	13	groups	group	NOUN
dpc-1565	47	14	.	.	PUNCT
dpc-1565	48	1	the	the	DET
dpc-1565	48	2	number	number	NOUN
dpc-1565	48	3	of	of	ADP
dpc-1565	48	4	papules	papule	NOUN
dpc-1565	48	5	and	and	CCONJ
dpc-1565	48	6	pustules	pustule	NOUN
dpc-1565	48	7	did	do	AUX
dpc-1565	48	8	not	not	PART
dpc-1565	48	9	change	change	VERB
dpc-1565	48	10	significantly	significantly	ADV
dpc-1565	48	11	in	in	ADP
dpc-1565	48	12	these	these	DET
dpc-1565	48	13	groups	group	NOUN
dpc-1565	48	14	over	over	ADP
dpc-1565	48	15	1	1	NUM
dpc-1565	48	16	month	month	NOUN
dpc-1565	48	17	(	(	PUNCT
dpc-1565	48	18	in	in	ADP
dpc-1565	48	19	both	both	DET
dpc-1565	48	20	groups	group	NOUN
dpc-1565	48	21	;	;	PUNCT
dpc-1565	48	22	p	p	X
dpc-1565	48	23	>	>	X
dpc-1565	48	24	0.05	0.05	NUM
dpc-1565	48	25	)	)	PUNCT
dpc-1565	48	26	.	.	PUNCT
dpc-1565	49	1	the	the	DET
dpc-1565	49	2	number	number	NOUN
dpc-1565	49	3	of	of	ADP
dpc-1565	49	4	pustules	pustule	NOUN
dpc-1565	49	5	decreased	decrease	VERB
dpc-1565	49	6	in	in	ADP
dpc-1565	49	7	the	the	DET
dpc-1565	49	8	female	female	ADJ
dpc-1565	49	9	group	group	NOUN
dpc-1565	49	10	(	(	PUNCT
dpc-1565	49	11	p	p	NOUN
dpc-1565	49	12	=	=	NOUN
dpc-1565	49	13	0.005	0.005	NUM
dpc-1565	49	14	)	)	PUNCT
dpc-1565	49	15	but	but	CCONJ
dpc-1565	49	16	the	the	DET
dpc-1565	49	17	number	number	NOUN
dpc-1565	49	18	of	of	ADP
dpc-1565	49	19	papules	papule	NOUN
dpc-1565	49	20	did	do	AUX
dpc-1565	49	21	not	not	PART
dpc-1565	49	22	change	change	VERB
dpc-1565	49	23	remarkably	remarkably	ADV
dpc-1565	49	24	(	(	PUNCT
dpc-1565	49	25	p	p	X
dpc-1565	49	26	>	>	X
dpc-1565	49	27	0.05	0.05	NUM
dpc-1565	49	28	)	)	PUNCT
dpc-1565	49	29	.	.	PUNCT
dpc-1565	50	1	table	table	NOUN
dpc-1565	50	2	3	3	NUM
dpc-1565	50	3	shows	show	VERB
dpc-1565	50	4	the	the	DET
dpc-1565	50	5	statistical	statistical	ADJ
dpc-1565	50	6	analysis	analysis	NOUN
dpc-1565	50	7	for	for	ADP
dpc-1565	50	8	males	male	NOUN
dpc-1565	50	9	vs	vs	ADP
dpc-1565	50	10	females	female	NOUN
dpc-1565	50	11	.	.	PUNCT
dpc-1565	51	1	topical	topical	ADJ
dpc-1565	51	2	application	application	NOUN
dpc-1565	51	3	of	of	ADP
dpc-1565	51	4	sodium	sodium	NOUN
dpc-1565	51	5	hypochlorite	hypochlorite	NOUN
dpc-1565	51	6	caused	cause	VERB
dpc-1565	51	7	more	more	ADJ
dpc-1565	51	8	acne	acne	NOUN
dpc-1565	51	9	remission	remission	NOUN
dpc-1565	51	10	in	in	ADP
dpc-1565	51	11	the	the	DET
dpc-1565	51	12	female	female	ADJ
dpc-1565	51	13	group	group	NOUN
dpc-1565	51	14	than	than	ADP
dpc-1565	51	15	in	in	ADP
dpc-1565	51	16	the	the	DET
dpc-1565	51	17	male	male	ADJ
dpc-1565	51	18	group	group	NOUN
dpc-1565	51	19	(	(	PUNCT
dpc-1565	51	20	p	p	X
dpc-1565	51	21	>	>	X
dpc-1565	51	22	0.05	0.05	NUM
dpc-1565	51	23	)	)	PUNCT
dpc-1565	51	24	.	.	PUNCT
dpc-1565	52	1	table	table	NOUN
dpc-1565	53	1	1	1	NUM
dpc-1565	53	2	.	.	PUNCT
dpc-1565	53	3	mean	mean	INTJ
dpc-1565	53	4	rank	rank	NOUN
dpc-1565	53	5	of	of	ADP
dpc-1565	53	6	papules	papule	NOUN
dpc-1565	53	7	and	and	CCONJ
dpc-1565	53	8	pustules	pustule	NOUN
dpc-1565	53	9	in	in	ADP
dpc-1565	53	10	40	40	NUM
dpc-1565	53	11	acne	acne	NOUN
dpc-1565	53	12	patients	patient	NOUN
dpc-1565	53	13	who	who	PRON
dpc-1565	53	14	received	receive	VERB
dpc-1565	53	15	either	either	CCONJ
dpc-1565	53	16	hypochlorite	hypochlorite	ADJ
dpc-1565	53	17	sodium	sodium	NOUN
dpc-1565	53	18	or	or	CCONJ
dpc-1565	53	19	placebo	placebo	NOUN
dpc-1565	53	20	over	over	ADP
dpc-1565	53	21	one	one	NUM
dpc-1565	53	22	month	month	NOUN
dpc-1565	53	23	hypochlorite	hypochlorite	NOUN
dpc-1565	53	24	group	group	NOUN
dpc-1565	53	25	placebo	placebo	NOUN
dpc-1565	53	26	group	group	NOUN
dpc-1565	53	27	p	p	NOUN
dpc-1565	53	28	value	value	NOUN
dpc-1565	53	29	papules	papule	NOUN
dpc-1565	53	30	week	week	NOUN
dpc-1565	53	31	1	1	NUM
dpc-1565	53	32	9.83	9.83	NUM
dpc-1565	53	33	9.33	9.33	NUM
dpc-1565	53	34	0.319	0.319	NUM
dpc-1565	53	35	week	week	NOUN
dpc-1565	53	36	2	2	NUM
dpc-1565	53	37	6.99	6.99	NUM
dpc-1565	53	38	7.78	7.78	NUM
dpc-1565	53	39	0.266	0.266	NUM
dpc-1565	53	40	week	week	NOUN
dpc-1565	53	41	4	4	NUM
dpc-1565	53	42	5.85	5.85	NUM
dpc-1565	53	43	7.66	7.66	NUM
dpc-1565	53	44	0.015	0.015	NUM
dpc-1565	53	45	pustules	pustule	NOUN
dpc-1565	53	46	week	week	NOUN
dpc-1565	53	47	1	1	NUM
dpc-1565	53	48	7.99	7.99	NUM
dpc-1565	53	49	5.28	5.28	NUM
dpc-1565	53	50	0.003	0.003	NUM
dpc-1565	53	51	week	week	NOUN
dpc-1565	53	52	2	2	NUM
dpc-1565	53	53	4.14	4.14	NUM
dpc-1565	53	54	5.25	5.25	NUM
dpc-1565	53	55	0.029	0.029	NUM
dpc-1565	53	56	week	week	NOUN
dpc-1565	53	57	4	4	NUM
dpc-1565	53	58	2.93	2.93	NUM
dpc-1565	53	59	5.00	5.00	NUM
dpc-1565	53	60	0.002	0.002	NUM
dpc-1565	53	61	research	research	NOUN
dpc-1565	53	62	|	|	ADV
dpc-1565	53	63	dermatol	dermatol	NOUN
dpc-1565	53	64	pract	pract	NOUN
dpc-1565	53	65	concept	concept	NOUN
dpc-1565	53	66	.	.	PUNCT
dpc-1565	54	1	2021;11(3):e2021046	2021;11(3):e2021046	CCONJ
dpc-1565	54	2	3	3	NUM
dpc-1565	54	3	discussion	discussion	NOUN
dpc-1565	54	4	our	our	PRON
dpc-1565	54	5	study	study	NOUN
dpc-1565	54	6	shows	show	VERB
dpc-1565	54	7	that	that	SCONJ
dpc-1565	54	8	the	the	DET
dpc-1565	54	9	total	total	ADJ
dpc-1565	54	10	number	number	NOUN
dpc-1565	54	11	of	of	ADP
dpc-1565	54	12	acne	acne	NOUN
dpc-1565	54	13	lesions	lesion	NOUN
dpc-1565	54	14	decreased	decrease	VERB
dpc-1565	54	15	significantly	significantly	ADV
dpc-1565	54	16	after	after	ADP
dpc-1565	54	17	applying	apply	VERB
dpc-1565	54	18	sodium	sodium	NOUN
dpc-1565	54	19	hypochlorite	hypochlorite	NOUN
dpc-1565	54	20	0.005	0.005	NUM
dpc-1565	54	21	%	%	NOUN
dpc-1565	54	22	topically	topically	ADV
dpc-1565	54	23	3	3	NUM
dpc-1565	54	24	times	time	NOUN
dpc-1565	54	25	a	a	DET
dpc-1565	54	26	day	day	NOUN
dpc-1565	54	27	for	for	ADP
dpc-1565	54	28	1	1	NUM
dpc-1565	54	29	month	month	NOUN
dpc-1565	54	30	.	.	PUNCT
dpc-1565	55	1	consequently	consequently	ADV
dpc-1565	55	2	,	,	PUNCT
dpc-1565	55	3	topical	topical	ADJ
dpc-1565	55	4	application	application	NOUN
dpc-1565	55	5	of	of	ADP
dpc-1565	55	6	sodium	sodium	NOUN
dpc-1565	55	7	hypochlorite	hypochlorite	NOUN
dpc-1565	55	8	0.005	0.005	NUM
dpc-1565	55	9	%	%	NOUN
dpc-1565	55	10	can	can	AUX
dpc-1565	55	11	be	be	AUX
dpc-1565	55	12	effective	effective	ADJ
dpc-1565	55	13	in	in	ADP
dpc-1565	55	14	the	the	DET
dpc-1565	55	15	treatment	treatment	NOUN
dpc-1565	55	16	of	of	ADP
dpc-1565	55	17	mild	mild	ADJ
dpc-1565	55	18	to	to	ADP
dpc-1565	55	19	moderate	moderate	ADJ
dpc-1565	55	20	acne	acne	NOUN
dpc-1565	55	21	.	.	PUNCT
dpc-1565	56	1	a	a	DET
dpc-1565	56	2	reduction	reduction	NOUN
dpc-1565	56	3	in	in	ADP
dpc-1565	56	4	the	the	DET
dpc-1565	56	5	total	total	ADJ
dpc-1565	56	6	number	number	NOUN
dpc-1565	56	7	of	of	ADP
dpc-1565	56	8	papules	papule	NOUN
dpc-1565	56	9	and	and	CCONJ
dpc-1565	56	10	pustules	pustule	NOUN
dpc-1565	56	11	highlights	highlight	VERB
dpc-1565	56	12	the	the	DET
dpc-1565	56	13	antimicrobial	antimicrobial	ADJ
dpc-1565	56	14	properties	property	NOUN
dpc-1565	56	15	of	of	ADP
dpc-1565	56	16	sodium	sodium	NOUN
dpc-1565	56	17	hypochlorite	hypochlorite	NOUN
dpc-1565	56	18	.	.	PUNCT
dpc-1565	57	1	del	del	PROPN
dpc-1565	57	2	rosso	rosso	NOUN
dpc-1565	57	3	and	and	CCONJ
dpc-1565	57	4	colleagues	colleague	NOUN
dpc-1565	57	5	reported	report	VERB
dpc-1565	57	6	that	that	SCONJ
dpc-1565	57	7	sodium	sodium	NOUN
dpc-1565	57	8	hypochlorite	hypochlorite	NOUN
dpc-1565	57	9	was	be	AUX
dpc-1565	57	10	an	an	DET
dpc-1565	57	11	effective	effective	ADJ
dpc-1565	57	12	antimicrobial	antimicrobial	ADJ
dpc-1565	57	13	agent	agent	NOUN
dpc-1565	57	14	to	to	PART
dpc-1565	57	15	decrease	decrease	VERB
dpc-1565	57	16	the	the	DET
dpc-1565	57	17	load	load	NOUN
dpc-1565	57	18	of	of	ADP
dpc-1565	57	19	s.	s.	PROPN
dpc-1565	57	20	aureus	aureus	PROPN
dpc-1565	57	21	in	in	ADP
dpc-1565	57	22	atopic	atopic	NOUN
dpc-1565	57	23	dermatitis	dermatitis	NOUN
dpc-1565	57	24	lesions	lesion	NOUN
dpc-1565	57	25	[	[	X
dpc-1565	57	26	8	8	NUM
dpc-1565	57	27	]	]	PUNCT
dpc-1565	57	28	.	.	PUNCT
dpc-1565	58	1	coetzee	coetzee	PROPN
dpc-1565	58	2	and	and	CCONJ
dpc-1565	58	3	colleagues	colleague	NOUN
dpc-1565	58	4	indicated	indicate	VERB
dpc-1565	58	5	that	that	SCONJ
dpc-1565	58	6	an	an	DET
dpc-1565	58	7	un	un	ADJ
dpc-1565	58	8	-	-	ADJ
dpc-1565	58	9	buffered	buffer	VERB
dpc-1565	58	10	solution	solution	NOUN
dpc-1565	58	11	of	of	ADP
dpc-1565	58	12	sodium	sodium	NOUN
dpc-1565	58	13	hypochlorite	hypochlorite	NOUN
dpc-1565	58	14	0.006	0.006	NUM
dpc-1565	58	15	%	%	NOUN
dpc-1565	58	16	was	be	AUX
dpc-1565	58	17	effective	effective	ADJ
dpc-1565	58	18	in	in	ADP
dpc-1565	58	19	the	the	DET
dpc-1565	58	20	management	management	NOUN
dpc-1565	58	21	of	of	ADP
dpc-1565	58	22	infected	infect	VERB
dpc-1565	58	23	burn	burn	NOUN
dpc-1565	58	24	wounds	wound	NOUN
dpc-1565	58	25	caused	cause	VERB
dpc-1565	58	26	by	by	ADP
dpc-1565	58	27	pseudomonas	pseudomona	NOUN
dpc-1565	58	28	aeruginosa	aeruginosa	NOUN
dpc-1565	58	29	,	,	PUNCT
dpc-1565	58	30	s.	s.	PROPN
dpc-1565	58	31	aureus	aureus	PROPN
dpc-1565	58	32	and	and	CCONJ
dpc-1565	58	33	streptococcus	streptococcus	VERB
dpc-1565	58	34	pyogenes	pyogene	NOUN
dpc-1565	58	35	[	[	X
dpc-1565	58	36	9	9	NUM
dpc-1565	58	37	]	]	PUNCT
dpc-1565	58	38	.	.	PUNCT
dpc-1565	59	1	consequently	consequently	ADV
dpc-1565	59	2	,	,	PUNCT
dpc-1565	59	3	sodium	sodium	NOUN
dpc-1565	59	4	hypochlorite	hypochlorite	NOUN
dpc-1565	59	5	can	can	AUX
dpc-1565	59	6	possibly	possibly	ADV
dpc-1565	59	7	be	be	AUX
dpc-1565	59	8	helpful	helpful	ADJ
dpc-1565	59	9	to	to	PART
dpc-1565	59	10	decrease	decrease	VERB
dpc-1565	59	11	the	the	DET
dpc-1565	59	12	load	load	NOUN
dpc-1565	59	13	of	of	ADP
dpc-1565	59	14	propionibacterium	propionibacterium	NOUN
dpc-1565	59	15	acnes	acne	NOUN
dpc-1565	59	16	in	in	ADP
dpc-1565	59	17	acne	acne	NOUN
dpc-1565	59	18	lesions	lesion	NOUN
dpc-1565	59	19	.	.	PUNCT
dpc-1565	60	1	a	a	DET
dpc-1565	60	2	reduction	reduction	NOUN
dpc-1565	60	3	of	of	ADP
dpc-1565	60	4	pustules	pustule	NOUN
dpc-1565	60	5	in	in	ADP
dpc-1565	60	6	the	the	DET
dpc-1565	60	7	female	female	ADJ
dpc-1565	60	8	group	group	NOUN
dpc-1565	60	9	was	be	AUX
dpc-1565	60	10	associated	associate	VERB
dpc-1565	60	11	with	with	ADP
dpc-1565	60	12	the	the	DET
dpc-1565	60	13	topical	topical	ADJ
dpc-1565	60	14	application	application	NOUN
dpc-1565	60	15	of	of	ADP
dpc-1565	60	16	sodium	sodium	NOUN
dpc-1565	60	17	hypochlorite	hypochlorite	NOUN
dpc-1565	60	18	0.005	0.005	NUM
dpc-1565	60	19	%	%	NOUN
dpc-1565	60	20	.	.	PUNCT
dpc-1565	61	1	consequently	consequently	ADV
dpc-1565	61	2	,	,	PUNCT
dpc-1565	61	3	we	we	PRON
dpc-1565	61	4	can	can	AUX
dpc-1565	61	5	use	use	VERB
dpc-1565	61	6	it	it	PRON
dpc-1565	61	7	as	as	ADP
dpc-1565	61	8	a	a	DET
dpc-1565	61	9	treatment	treatment	NOUN
dpc-1565	61	10	for	for	ADP
dpc-1565	61	11	female	female	ADJ
dpc-1565	61	12	acne	acne	NOUN
dpc-1565	61	13	similar	similar	ADJ
dpc-1565	61	14	to	to	ADP
dpc-1565	61	15	other	other	ADJ
dpc-1565	61	16	topical	topical	ADJ
dpc-1565	61	17	products	product	NOUN
dpc-1565	61	18	[	[	X
dpc-1565	61	19	10	10	NUM
dpc-1565	61	20	]	]	PUNCT
dpc-1565	61	21	.	.	PUNCT
dpc-1565	62	1	preneau	preneau	NOUN
dpc-1565	62	2	and	and	CCONJ
dpc-1565	62	3	dreno	dreno	NOUN
dpc-1565	62	4	showed	show	VERB
dpc-1565	62	5	that	that	SCONJ
dpc-1565	62	6	female	female	ADJ
dpc-1565	62	7	acne	acne	NOUN
dpc-1565	62	8	is	be	AUX
dpc-1565	62	9	a	a	DET
dpc-1565	62	10	common	common	ADJ
dpc-1565	62	11	female	female	ADJ
dpc-1565	62	12	disease	disease	NOUN
dpc-1565	62	13	(	(	PUNCT
dpc-1565	62	14	40%-50	40%-50	NUM
dpc-1565	62	15	%	%	NOUN
dpc-1565	62	16	)	)	PUNCT
dpc-1565	62	17	that	that	PRON
dpc-1565	62	18	should	should	AUX
dpc-1565	62	19	be	be	AUX
dpc-1565	62	20	treated	treat	VERB
dpc-1565	62	21	differently	differently	ADV
dpc-1565	62	22	from	from	ADP
dpc-1565	62	23	adolescent	adolescent	ADJ
dpc-1565	62	24	acne	acne	NOUN
dpc-1565	62	25	because	because	SCONJ
dpc-1565	62	26	of	of	ADP
dpc-1565	62	27	differences	difference	NOUN
dpc-1565	62	28	in	in	ADP
dpc-1565	62	29	the	the	DET
dpc-1565	62	30	clinical	clinical	ADJ
dpc-1565	62	31	scale	scale	NOUN
dpc-1565	62	32	and	and	CCONJ
dpc-1565	62	33	therapeutic	therapeutic	ADJ
dpc-1565	62	34	algorithm	algorithm	NOUN
dpc-1565	62	35	[	[	X
dpc-1565	62	36	11	11	NUM
dpc-1565	62	37	]	]	PUNCT
dpc-1565	62	38	.	.	PUNCT
dpc-1565	63	1	acne	acne	NOUN
dpc-1565	63	2	therapy	therapy	NOUN
dpc-1565	63	3	comprises	comprise	VERB
dpc-1565	63	4	several	several	ADJ
dpc-1565	63	5	options	option	NOUN
dpc-1565	63	6	,	,	PUNCT
dpc-1565	63	7	but	but	CCONJ
dpc-1565	63	8	the	the	DET
dpc-1565	63	9	efficacy	efficacy	NOUN
dpc-1565	63	10	and	and	CCONJ
dpc-1565	63	11	adverse	adverse	ADJ
dpc-1565	63	12	events	event	NOUN
dpc-1565	63	13	of	of	ADP
dpc-1565	63	14	each	each	DET
dpc-1565	63	15	treatment	treatment	NOUN
dpc-1565	63	16	are	be	AUX
dpc-1565	63	17	under	under	ADP
dpc-1565	63	18	investigation	investigation	NOUN
dpc-1565	63	19	.	.	PUNCT
dpc-1565	64	1	by	by	ADP
dpc-1565	64	2	way	way	NOUN
dpc-1565	64	3	of	of	ADP
dpc-1565	64	4	illustration	illustration	NOUN
dpc-1565	64	5	,	,	PUNCT
dpc-1565	64	6	treatment	treatment	NOUN
dpc-1565	64	7	with	with	ADP
dpc-1565	64	8	oral	oral	ADJ
dpc-1565	64	9	antibiotics	antibiotic	NOUN
dpc-1565	64	10	is	be	AUX
dpc-1565	64	11	long	long	ADV
dpc-1565	64	12	-	-	PUNCT
dpc-1565	64	13	lasting	last	VERB
dpc-1565	64	14	because	because	SCONJ
dpc-1565	64	15	of	of	ADP
dpc-1565	64	16	bacterial	bacterial	ADJ
dpc-1565	64	17	resistance	resistance	NOUN
dpc-1565	64	18	,	,	PUNCT
dpc-1565	64	19	adverse	adverse	ADJ
dpc-1565	64	20	effects	effect	NOUN
dpc-1565	64	21	table	table	NOUN
dpc-1565	64	22	2	2	NUM
dpc-1565	64	23	.	.	PUNCT
dpc-1565	64	24	ranking	rank	VERB
dpc-1565	64	25	of	of	ADP
dpc-1565	64	26	papules	papule	NOUN
dpc-1565	64	27	and	and	CCONJ
dpc-1565	64	28	pustules	pustule	NOUN
dpc-1565	64	29	in	in	ADP
dpc-1565	64	30	the	the	DET
dpc-1565	64	31	patients	patient	NOUN
dpc-1565	64	32	with	with	ADP
dpc-1565	64	33	hormonal	hormonal	ADJ
dpc-1565	64	34	and	and	CCONJ
dpc-1565	64	35	non	non	ADJ
dpc-1565	64	36	-	-	ADJ
dpc-1565	64	37	hormonal	hormonal	ADJ
dpc-1565	64	38	acne	acne	NOUN
dpc-1565	64	39	who	who	PRON
dpc-1565	64	40	received	receive	VERB
dpc-1565	64	41	hypochlorite	hypochlorite	ADJ
dpc-1565	64	42	sodium	sodium	NOUN
dpc-1565	64	43	or	or	CCONJ
dpc-1565	64	44	placebo	placebo	NOUN
dpc-1565	64	45	over	over	ADP
dpc-1565	64	46	1	1	NUM
dpc-1565	64	47	month	month	NOUN
dpc-1565	64	48	.	.	PUNCT
dpc-1565	65	1	hypochlorite	hypochlorite	NOUN
dpc-1565	65	2	group	group	NOUN
dpc-1565	65	3	placebo	placebo	NOUN
dpc-1565	65	4	group	group	NOUN
dpc-1565	65	5	p	p	NOUN
dpc-1565	65	6	value	value	NOUN
dpc-1565	65	7	hormonal	hormonal	ADJ
dpc-1565	65	8	papules	papule	NOUN
dpc-1565	65	9	week	week	NOUN
dpc-1565	65	10	1	1	NUM
dpc-1565	65	11	3.00	3.00	NUM
dpc-1565	65	12	7.00	7.00	NUM
dpc-1565	65	13	0.673	0.673	NUM
dpc-1565	65	14	week	week	NOUN
dpc-1565	65	15	2	2	NUM
dpc-1565	65	16	5.33	5.33	NUM
dpc-1565	65	17	5.75	5.75	NUM
dpc-1565	65	18	0.645	0.645	NUM
dpc-1565	65	19	week	week	NOUN
dpc-1565	65	20	4	4	NUM
dpc-1565	65	21	5.75	5.75	NUM
dpc-1565	65	22	5.13	5.13	NUM
dpc-1565	65	23	0.473	0.473	NUM
dpc-1565	65	24	hormonal	hormonal	ADJ
dpc-1565	65	25	pustules	pustule	NOUN
dpc-1565	65	26	week	week	NOUN
dpc-1565	65	27	1	1	NUM
dpc-1565	65	28	3.67	3.67	NUM
dpc-1565	65	29	5.67	5.67	NUM
dpc-1565	65	30	0.170	0.170	NUM
dpc-1565	65	31	week	week	NOUN
dpc-1565	65	32	2	2	NUM
dpc-1565	65	33	5.81	5.81	NUM
dpc-1565	65	34	4.25	4.25	NUM
dpc-1565	65	35	0.051	0.051	NUM
dpc-1565	65	36	week	week	NOUN
dpc-1565	65	37	4	4	NUM
dpc-1565	65	38	5.13	5.13	NUM
dpc-1565	65	39	4.00	4.00	NUM
dpc-1565	65	40	0.028	0.028	NUM
dpc-1565	65	41	non	non	ADJ
dpc-1565	65	42	-	-	ADJ
dpc-1565	65	43	hormonal	hormonal	ADJ
dpc-1565	65	44	papules	papule	NOUN
dpc-1565	65	45	week	week	NOUN
dpc-1565	65	46	1	1	NUM
dpc-1565	65	47	10.15	10.15	NUM
dpc-1565	65	48	16.08	16.08	NUM
dpc-1565	65	49	0.410	0.410	NUM
dpc-1565	65	50	week	week	NOUN
dpc-1565	65	51	2	2	NUM
dpc-1565	65	52	11.47	11.47	NUM
dpc-1565	65	53	13.00	13.00	NUM
dpc-1565	65	54	0.299	0.299	NUM
dpc-1565	65	55	week	week	NOUN
dpc-1565	65	56	4	4	NUM
dpc-1565	65	57	14.53	14.53	NUM
dpc-1565	65	58	12.50	12.50	NUM
dpc-1565	65	59	0.014	0.014	NUM
dpc-1565	65	60	non	non	ADJ
dpc-1565	65	61	-	-	ADJ
dpc-1565	65	62	hormonal	hormonal	ADJ
dpc-1565	65	63	pustules	pustule	NOUN
dpc-1565	65	64	week	week	NOUN
dpc-1565	65	65	1	1	NUM
dpc-1565	65	66	8.75	8.75	NUM
dpc-1565	65	67	13.15	13.15	NUM
dpc-1565	65	68	0.009	0.009	NUM
dpc-1565	65	69	week	week	NOUN
dpc-1565	65	70	2	2	NUM
dpc-1565	65	71	14.88	14.88	NUM
dpc-1565	65	72	9.68	9.68	NUM
dpc-1565	65	73	0.206	0.206	NUM
dpc-1565	65	74	week	week	NOUN
dpc-1565	65	75	4	4	NUM
dpc-1565	65	76	13.53	13.53	NUM
dpc-1565	65	77	11.64	11.64	NUM
dpc-1565	65	78	0.028	0.028	NUM
dpc-1565	65	79	table	table	NOUN
dpc-1565	65	80	3	3	NUM
dpc-1565	65	81	.	.	PUNCT
dpc-1565	65	82	mean	mean	PROPN
dpc-1565	65	83	rank	rank	NOUN
dpc-1565	65	84	of	of	ADP
dpc-1565	65	85	papules	papule	NOUN
dpc-1565	65	86	and	and	CCONJ
dpc-1565	65	87	pustules	pustule	NOUN
dpc-1565	65	88	in	in	ADP
dpc-1565	65	89	the	the	DET
dpc-1565	65	90	male	male	ADJ
dpc-1565	65	91	and	and	CCONJ
dpc-1565	65	92	female	female	ADJ
dpc-1565	65	93	patients	patient	NOUN
dpc-1565	65	94	who	who	PRON
dpc-1565	65	95	received	receive	VERB
dpc-1565	65	96	hypochlorite	hypochlorite	ADJ
dpc-1565	65	97	sodium	sodium	NOUN
dpc-1565	65	98	or	or	CCONJ
dpc-1565	65	99	placebo	placebo	NOUN
dpc-1565	65	100	over	over	ADP
dpc-1565	65	101	1	1	NUM
dpc-1565	65	102	month	month	NOUN
dpc-1565	65	103	.	.	PUNCT
dpc-1565	66	1	hypochlorite	hypochlorite	NOUN
dpc-1565	66	2	group	group	NOUN
dpc-1565	66	3	placebo	placebo	NOUN
dpc-1565	66	4	group	group	NOUN
dpc-1565	66	5	p	p	NOUN
dpc-1565	66	6	value	value	NOUN
dpc-1565	66	7	male	male	ADJ
dpc-1565	66	8	papules	papule	NOUN
dpc-1565	66	9	week	week	NOUN
dpc-1565	66	10	1	1	NUM
dpc-1565	66	11	4.14	4.14	NUM
dpc-1565	66	12	7.00	7.00	NUM
dpc-1565	66	13	0.107	0.107	NUM
dpc-1565	66	14	week	week	NOUN
dpc-1565	66	15	2	2	NUM
dpc-1565	66	16	4.92	4.92	NUM
dpc-1565	66	17	5.17	5.17	NUM
dpc-1565	66	18	0.399	0.399	NUM
dpc-1565	66	19	week	week	NOUN
dpc-1565	66	20	4	4	NUM
dpc-1565	66	21	5.21	5.21	NUM
dpc-1565	66	22	4.25	4.25	NUM
dpc-1565	66	23	0.095	0.095	NUM
dpc-1565	66	24	male	male	ADJ
dpc-1565	66	25	pustules	pustule	NOUN
dpc-1565	66	26	week	week	NOUN
dpc-1565	66	27	1	1	NUM
dpc-1565	66	28	3.25	3.25	NUM
dpc-1565	66	29	4.30	4.30	NUM
dpc-1565	66	30	0.201	0.201	NUM
dpc-1565	66	31	week	week	NOUN
dpc-1565	66	32	2	2	NUM
dpc-1565	66	33	5.33	5.33	NUM
dpc-1565	66	34	4.33	4.33	NUM
dpc-1565	66	35	0.252	0.252	NUM
dpc-1565	66	36	week	week	NOUN
dpc-1565	66	37	4	4	NUM
dpc-1565	66	38	4.67	4.67	NUM
dpc-1565	66	39	4.00	4.00	NUM
dpc-1565	66	40	0.158	0.158	NUM
dpc-1565	66	41	female	female	ADJ
dpc-1565	66	42	papules	papule	NOUN
dpc-1565	66	43	week	week	NOUN
dpc-1565	66	44	1	1	NUM
dpc-1565	66	45	9.59	9.59	NUM
dpc-1565	66	46	15.68	15.68	NUM
dpc-1565	66	47	0.124	0.124	NUM
dpc-1565	66	48	week	week	NOUN
dpc-1565	66	49	2	2	NUM
dpc-1565	66	50	11.50	11.50	NUM
dpc-1565	66	51	14.17	14.17	NUM
dpc-1565	66	52	0.518	0.518	NUM
dpc-1565	66	53	week	week	NOUN
dpc-1565	66	54	4	4	NUM
dpc-1565	66	55	14.97	14.97	NUM
dpc-1565	66	56	13.50	13.50	NUM
dpc-1565	66	57	0.062	0.062	NUM
dpc-1565	66	58	female	female	ADJ
dpc-1565	66	59	pustules	pustule	NOUN
dpc-1565	66	60	week	week	NOUN
dpc-1565	67	1	1	1	NUM
dpc-1565	67	2	9.21	9.21	NUM
dpc-1565	67	3	14.47	14.47	NUM
dpc-1565	67	4	0.008	0.008	NUM
dpc-1565	67	5	week	week	NOUN
dpc-1565	67	6	2	2	NUM
dpc-1565	67	7	15.47	15.47	NUM
dpc-1565	67	8	9.30	9.30	NUM
dpc-1565	67	9	0.058	0.058	NUM
dpc-1565	67	10	week	week	NOUN
dpc-1565	67	11	4	4	NUM
dpc-1565	67	12	14.25	14.25	NUM
dpc-1565	67	13	11.00	11.00	NUM
dpc-1565	67	14	0.005	0.005	NUM
dpc-1565	67	15	4	4	NUM
dpc-1565	67	16	research	research	NOUN
dpc-1565	67	17	|	|	ADV
dpc-1565	67	18	dermatol	dermatol	ADJ
dpc-1565	67	19	pract	pract	NOUN
dpc-1565	67	20	concept	concept	NOUN
dpc-1565	67	21	.	.	PUNCT
dpc-1565	68	1	2021;11(3):e2021046	2021;11(3):e2021046	NUM
dpc-1565	68	2	and	and	CCONJ
dpc-1565	68	3	low	low	ADJ
dpc-1565	68	4	efficacy	efficacy	NOUN
dpc-1565	68	5	during	during	ADP
dpc-1565	68	6	short	short	ADJ
dpc-1565	68	7	-	-	PUNCT
dpc-1565	68	8	term	term	NOUN
dpc-1565	68	9	application	application	NOUN
dpc-1565	68	10	.	.	PUNCT
dpc-1565	69	1	additionally	additionally	ADV
dpc-1565	69	2	,	,	PUNCT
dpc-1565	69	3	acne	acne	NOUN
dpc-1565	69	4	therapy	therapy	NOUN
dpc-1565	69	5	with	with	ADP
dpc-1565	69	6	isotretinoin	isotretinoin	PROPN
dpc-1565	69	7	is	be	AUX
dpc-1565	69	8	teratogenic	teratogenic	ADJ
dpc-1565	69	9	with	with	ADP
dpc-1565	69	10	noticeable	noticeable	ADJ
dpc-1565	69	11	side	side	NOUN
dpc-1565	69	12	effects	effect	NOUN
dpc-1565	69	13	;	;	PUNCT
dpc-1565	69	14	thus	thus	ADV
dpc-1565	69	15	,	,	PUNCT
dpc-1565	69	16	it	it	PRON
dpc-1565	69	17	needs	need	VERB
dpc-1565	69	18	close	close	ADJ
dpc-1565	69	19	follow	follow	NOUN
dpc-1565	69	20	-	-	PUNCT
dpc-1565	69	21	up	up	NOUN
dpc-1565	69	22	.	.	PUNCT
dpc-1565	70	1	hormonal	hormonal	ADJ
dpc-1565	70	2	therapy	therapy	NOUN
dpc-1565	70	3	is	be	AUX
dpc-1565	70	4	limited	limit	VERB
dpc-1565	70	5	to	to	ADP
dpc-1565	70	6	female	female	ADJ
dpc-1565	70	7	patients	patient	NOUN
dpc-1565	70	8	and	and	CCONJ
dpc-1565	70	9	its	its	PRON
dpc-1565	70	10	side	side	NOUN
dpc-1565	70	11	effects	effect	NOUN
dpc-1565	70	12	include	include	VERB
dpc-1565	70	13	abnormal	abnormal	ADJ
dpc-1565	70	14	menstruation	menstruation	NOUN
dpc-1565	70	15	,	,	PUNCT
dpc-1565	70	16	nausea	nausea	NOUN
dpc-1565	70	17	and	and	CCONJ
dpc-1565	70	18	vomiting	vomiting	NOUN
dpc-1565	70	19	,	,	PUNCT
dpc-1565	70	20	weight	weight	NOUN
dpc-1565	70	21	gain	gain	NOUN
dpc-1565	70	22	,	,	PUNCT
dpc-1565	70	23	breast	breast	NOUN
dpc-1565	70	24	tenderness	tenderness	NOUN
dpc-1565	70	25	,	,	PUNCT
dpc-1565	70	26	and	and	CCONJ
dpc-1565	70	27	higher	high	ADJ
dpc-1565	70	28	risk	risk	NOUN
dpc-1565	70	29	of	of	ADP
dpc-1565	70	30	thromboembolism	thromboembolism	NOUN
dpc-1565	71	1	[	[	X
dpc-1565	71	2	12	12	NUM
dpc-1565	71	3	]	]	PUNCT
dpc-1565	71	4	.	.	PUNCT
dpc-1565	72	1	furthermore	furthermore	ADV
dpc-1565	72	2	,	,	PUNCT
dpc-1565	72	3	costs	cost	NOUN
dpc-1565	72	4	and	and	CCONJ
dpc-1565	72	5	availability	availability	NOUN
dpc-1565	72	6	are	be	AUX
dpc-1565	72	7	considerable	considerable	ADJ
dpc-1565	72	8	factors	factor	NOUN
dpc-1565	72	9	of	of	ADP
dpc-1565	72	10	treatment	treatment	NOUN
dpc-1565	72	11	,	,	PUNCT
dpc-1565	72	12	especially	especially	ADV
dpc-1565	72	13	in	in	ADP
dpc-1565	72	14	developing	develop	VERB
dpc-1565	72	15	countries	country	NOUN
dpc-1565	72	16	.	.	PUNCT
dpc-1565	73	1	therefore	therefore	ADV
dpc-1565	73	2	,	,	PUNCT
dpc-1565	73	3	sodium	sodium	NOUN
dpc-1565	73	4	hypochlorite	hypochlorite	NOUN
dpc-1565	73	5	0.005	0.005	NUM
dpc-1565	73	6	%	%	NOUN
dpc-1565	73	7	can	can	AUX
dpc-1565	73	8	be	be	AUX
dpc-1565	73	9	a	a	DET
dpc-1565	73	10	suitable	suitable	ADJ
dpc-1565	73	11	option	option	NOUN
dpc-1565	73	12	for	for	ADP
dpc-1565	73	13	acne	acne	NOUN
dpc-1565	73	14	treatment	treatment	NOUN
dpc-1565	73	15	due	due	ADP
dpc-1565	73	16	to	to	ADP
dpc-1565	73	17	its	its	PRON
dpc-1565	73	18	low	low	ADJ
dpc-1565	73	19	cost	cost	NOUN
dpc-1565	73	20	,	,	PUNCT
dpc-1565	73	21	high	high	ADJ
dpc-1565	73	22	availability	availability	NOUN
dpc-1565	73	23	and	and	CCONJ
dpc-1565	73	24	few	few	ADJ
dpc-1565	73	25	side	side	NOUN
dpc-1565	73	26	effects	effect	NOUN
dpc-1565	73	27	.	.	PUNCT
dpc-1565	74	1	sodium	sodium	NOUN
dpc-1565	74	2	hypochlorite	hypochlorite	NOUN
dpc-1565	74	3	0.005	0.005	NUM
dpc-1565	74	4	%	%	NOUN
dpc-1565	74	5	was	be	AUX
dpc-1565	74	6	safe	safe	ADJ
dpc-1565	74	7	and	and	CCONJ
dpc-1565	74	8	well	well	ADV
dpc-1565	74	9	-	-	PUNCT
dpc-1565	74	10	tolerated	tolerate	VERB
dpc-1565	74	11	by	by	ADP
dpc-1565	74	12	patients	patient	NOUN
dpc-1565	74	13	of	of	ADP
dpc-1565	74	14	our	our	PRON
dpc-1565	74	15	study	study	NOUN
dpc-1565	74	16	,	,	PUNCT
dpc-1565	74	17	but	but	CCONJ
dpc-1565	74	18	skin	skin	NOUN
dpc-1565	74	19	-	-	PUNCT
dpc-1565	74	20	related	relate	VERB
dpc-1565	74	21	adverse	adverse	ADJ
dpc-1565	74	22	events	event	NOUN
dpc-1565	74	23	such	such	ADJ
dpc-1565	74	24	as	as	ADP
dpc-1565	74	25	skin	skin	NOUN
dpc-1565	74	26	irritation	irritation	NOUN
dpc-1565	74	27	or	or	CCONJ
dpc-1565	74	28	itching	itching	NOUN
dpc-1565	74	29	,	,	PUNCT
dpc-1565	74	30	and	and	CCONJ
dpc-1565	74	31	acne	acne	NOUN
dpc-1565	74	32	reoccurrence	reoccurrence	NOUN
dpc-1565	74	33	have	have	AUX
dpc-1565	74	34	been	be	AUX
dpc-1565	74	35	our	our	PRON
dpc-1565	74	36	concerns	concern	NOUN
dpc-1565	74	37	after	after	ADP
dpc-1565	74	38	discontinuation	discontinuation	NOUN
dpc-1565	74	39	of	of	ADP
dpc-1565	74	40	sodium	sodium	NOUN
dpc-1565	74	41	hypochlorite	hypochlorite	NOUN
dpc-1565	74	42	0.005	0.005	NUM
dpc-1565	74	43	%	%	NOUN
dpc-1565	74	44	.	.	PUNCT
dpc-1565	75	1	studies	study	NOUN
dpc-1565	75	2	have	have	AUX
dpc-1565	75	3	revealed	reveal	VERB
dpc-1565	75	4	that	that	SCONJ
dpc-1565	75	5	combination	combination	NOUN
dpc-1565	75	6	therapy	therapy	NOUN
dpc-1565	75	7	is	be	AUX
dpc-1565	75	8	more	more	ADV
dpc-1565	75	9	successful	successful	ADJ
dpc-1565	75	10	in	in	ADP
dpc-1565	75	11	acne	acne	NOUN
dpc-1565	75	12	treatment	treatment	NOUN
dpc-1565	75	13	.	.	PUNCT
dpc-1565	76	1	as	as	ADP
dpc-1565	76	2	a	a	DET
dpc-1565	76	3	result	result	NOUN
dpc-1565	76	4	,	,	PUNCT
dpc-1565	76	5	the	the	DET
dpc-1565	76	6	combination	combination	NOUN
dpc-1565	76	7	of	of	ADP
dpc-1565	76	8	sodium	sodium	NOUN
dpc-1565	76	9	hypochlorite	hypochlorite	NOUN
dpc-1565	76	10	0.005	0.005	NUM
dpc-1565	76	11	%	%	NOUN
dpc-1565	76	12	with	with	ADP
dpc-1565	76	13	retinoids	retinoid	NOUN
dpc-1565	76	14	or	or	CCONJ
dpc-1565	76	15	antibiotics	antibiotic	NOUN
dpc-1565	76	16	can	can	AUX
dpc-1565	76	17	improve	improve	VERB
dpc-1565	76	18	the	the	DET
dpc-1565	76	19	anti	anti	ADJ
dpc-1565	76	20	-	-	ADJ
dpc-1565	76	21	inflammatory	inflammatory	ADJ
dpc-1565	76	22	effects	effect	NOUN
dpc-1565	76	23	of	of	ADP
dpc-1565	76	24	the	the	DET
dpc-1565	76	25	treatment	treatment	NOUN
dpc-1565	76	26	regimen	regiman	NOUN
dpc-1565	76	27	or	or	CCONJ
dpc-1565	76	28	reduce	reduce	VERB
dpc-1565	76	29	the	the	DET
dpc-1565	76	30	resistance	resistance	NOUN
dpc-1565	76	31	to	to	ADP
dpc-1565	76	32	antibiotics	antibiotic	NOUN
dpc-1565	76	33	,	,	PUNCT
dpc-1565	76	34	respectively	respectively	ADV
dpc-1565	76	35	[	[	X
dpc-1565	76	36	2	2	NUM
dpc-1565	76	37	]	]	PUNCT
dpc-1565	76	38	.	.	PUNCT
dpc-1565	77	1	additionally	additionally	ADV
dpc-1565	77	2	,	,	PUNCT
dpc-1565	77	3	the	the	DET
dpc-1565	77	4	combination	combination	NOUN
dpc-1565	77	5	with	with	ADP
dpc-1565	77	6	compounds	compound	NOUN
dpc-1565	77	7	such	such	ADJ
dpc-1565	77	8	as	as	ADP
dpc-1565	77	9	azelaic	azelaic	PROPN
dpc-1565	77	10	acid	acid	NOUN
dpc-1565	77	11	,	,	PUNCT
dpc-1565	77	12	salicylic	salicylic	ADJ
dpc-1565	77	13	acid	acid	NOUN
dpc-1565	77	14	and	and	CCONJ
dpc-1565	77	15	tazarotene	tazarotene	NOUN
dpc-1565	77	16	can	can	AUX
dpc-1565	77	17	be	be	AUX
dpc-1565	77	18	effective	effective	ADJ
dpc-1565	77	19	in	in	ADP
dpc-1565	77	20	acne	acne	NOUN
dpc-1565	77	21	therapy	therapy	NOUN
dpc-1565	77	22	.	.	PUNCT
dpc-1565	78	1	as	as	SCONJ
dpc-1565	78	2	hidalgo	hidalgo	PROPN
dpc-1565	78	3	et	et	PROPN
dpc-1565	78	4	al	al	PROPN
dpc-1565	78	5	.	.	PROPN
dpc-1565	78	6	’s	’s	PART
dpc-1565	78	7	study	study	PROPN
dpc-1565	78	8	showed	show	VERB
dpc-1565	78	9	,	,	PUNCT
dpc-1565	78	10	the	the	DET
dpc-1565	78	11	bactericidal	bactericidal	ADJ
dpc-1565	78	12	effect	effect	NOUN
dpc-1565	78	13	of	of	ADP
dpc-1565	78	14	sodium	sodium	NOUN
dpc-1565	78	15	hypochlorite	hypochlorite	NOUN
dpc-1565	78	16	increases	increase	NOUN
dpc-1565	78	17	by	by	ADP
dpc-1565	78	18	reducing	reduce	VERB
dpc-1565	78	19	the	the	DET
dpc-1565	78	20	ph	ph	NOUN
dpc-1565	78	21	[	[	X
dpc-1565	78	22	5	5	NUM
dpc-1565	78	23	]	]	PUNCT
dpc-1565	78	24	.	.	PUNCT
dpc-1565	79	1	because	because	SCONJ
dpc-1565	79	2	our	our	PRON
dpc-1565	79	3	study	study	NOUN
dpc-1565	79	4	group	group	NOUN
dpc-1565	79	5	was	be	AUX
dpc-1565	79	6	small	small	ADJ
dpc-1565	79	7	,	,	PUNCT
dpc-1565	79	8	more	more	ADJ
dpc-1565	79	9	studies	study	NOUN
dpc-1565	79	10	with	with	ADP
dpc-1565	79	11	more	more	ADJ
dpc-1565	79	12	patients	patient	NOUN
dpc-1565	79	13	are	be	AUX
dpc-1565	79	14	needed	need	VERB
dpc-1565	79	15	to	to	PART
dpc-1565	79	16	determine	determine	VERB
dpc-1565	79	17	the	the	DET
dpc-1565	79	18	clinical	clinical	ADJ
dpc-1565	79	19	efficacy	efficacy	NOUN
dpc-1565	79	20	of	of	ADP
dpc-1565	79	21	sodium	sodium	NOUN
dpc-1565	79	22	hypochlorite	hypochlorite	NOUN
dpc-1565	79	23	0.005	0.005	NUM
dpc-1565	79	24	%	%	NOUN
dpc-1565	79	25	in	in	ADP
dpc-1565	79	26	acne	acne	NOUN
dpc-1565	79	27	therapy	therapy	NOUN
dpc-1565	79	28	.	.	PUNCT
dpc-1565	80	1	in	in	ADP
dpc-1565	80	2	conclusion	conclusion	NOUN
dpc-1565	80	3	,	,	PUNCT
dpc-1565	80	4	our	our	PRON
dpc-1565	80	5	randomized	randomize	VERB
dpc-1565	80	6	controlled	control	VERB
dpc-1565	80	7	trial	trial	NOUN
dpc-1565	80	8	demonstrates	demonstrate	VERB
dpc-1565	80	9	that	that	SCONJ
dpc-1565	80	10	sodium	sodium	NOUN
dpc-1565	80	11	hypochlorite	hypochlorite	NOUN
dpc-1565	80	12	0.005	0.005	NUM
dpc-1565	80	13	%	%	NOUN
dpc-1565	80	14	is	be	AUX
dpc-1565	80	15	an	an	DET
dpc-1565	80	16	effective	effective	ADJ
dpc-1565	80	17	and	and	CCONJ
dpc-1565	80	18	safe	safe	ADJ
dpc-1565	80	19	treatment	treatment	NOUN
dpc-1565	80	20	for	for	ADP
dpc-1565	80	21	acne	acne	NOUN
dpc-1565	80	22	,	,	PUNCT
dpc-1565	80	23	and	and	CCONJ
dpc-1565	80	24	that	that	SCONJ
dpc-1565	80	25	the	the	DET
dpc-1565	80	26	therapeutic	therapeutic	ADJ
dpc-1565	80	27	outcomes	outcome	NOUN
dpc-1565	80	28	were	be	AUX
dpc-1565	80	29	different	different	ADJ
dpc-1565	80	30	between	between	ADP
dpc-1565	80	31	hormonal	hormonal	ADJ
dpc-1565	80	32	and	and	CCONJ
dpc-1565	80	33	non	non	ADJ
dpc-1565	80	34	-	-	ADJ
dpc-1565	80	35	hormonal	hormonal	ADJ
dpc-1565	80	36	acne	acne	NOUN
dpc-1565	80	37	and	and	CCONJ
dpc-1565	80	38	between	between	ADP
dpc-1565	80	39	male	male	ADJ
dpc-1565	80	40	and	and	CCONJ
dpc-1565	80	41	female	female	ADJ
dpc-1565	80	42	groups	group	NOUN
dpc-1565	80	43	.	.	PUNCT
dpc-1565	81	1	references	reference	NOUN
dpc-1565	81	2	1	1	NUM
dpc-1565	81	3	.	.	PUNCT
dpc-1565	81	4	tan	tan	PROPN
dpc-1565	81	5	jk	jk	PROPN
dpc-1565	81	6	and	and	CCONJ
dpc-1565	81	7	bhate	bhate	VERB
dpc-1565	81	8	k.	k.	PROPN
dpc-1565	82	1	a	a	DET
dpc-1565	82	2	global	global	ADJ
dpc-1565	82	3	perspective	perspective	NOUN
dpc-1565	82	4	on	on	ADP
dpc-1565	82	5	the	the	DET
dpc-1565	82	6	epidemiology	epidemiology	NOUN
dpc-1565	82	7	of	of	ADP
dpc-1565	82	8	acne	acne	NOUN
dpc-1565	82	9	.	.	PUNCT
dpc-1565	83	1	br	br	PROPN
dpc-1565	83	2	j	j	PROPN
dpc-1565	83	3	dermatol	dermatol	NOUN
dpc-1565	83	4	.	.	PUNCT
dpc-1565	84	1	2015	2015	NUM
dpc-1565	84	2	.	.	PUNCT
dpc-1565	85	1	172	172	NUM
dpc-1565	85	2	suppl	suppl	ADJ
dpc-1565	85	3	1	1	NUM
dpc-1565	85	4	:	:	SYM
dpc-1565	85	5	3	3	NUM
dpc-1565	85	6	-	-	SYM
dpc-1565	85	7	12	12	NUM
dpc-1565	85	8	.	.	PUNCT
dpc-1565	86	1	doi	doi	NOUN
dpc-1565	86	2	:	:	PUNCT
dpc-1565	86	3	10.1111/	10.1111/	NUM
dpc-1565	86	4	bjd.13462	bjd.13462	NUM
dpc-1565	86	5	.	.	PUNCT
dpc-1565	87	1	pmid	pmid	NOUN
dpc-1565	87	2	:	:	PUNCT
dpc-1565	87	3	25597339	25597339	NUM
dpc-1565	87	4	2	2	NUM
dpc-1565	87	5	.	.	PUNCT
dpc-1565	87	6	fox	fox	PROPN
dpc-1565	87	7	l	l	PROPN
dpc-1565	87	8	,	,	PUNCT
dpc-1565	87	9	et	et	PROPN
dpc-1565	87	10	al	al	PROPN
dpc-1565	87	11	.	.	PUNCT
dpc-1565	87	12	treatment	treatment	NOUN
dpc-1565	87	13	modalities	modality	NOUN
dpc-1565	87	14	for	for	ADP
dpc-1565	87	15	acne	acne	NOUN
dpc-1565	87	16	.	.	PUNCT
dpc-1565	88	1	molecules	molecule	NOUN
dpc-1565	88	2	.	.	PUNCT
dpc-1565	89	1	2016	2016	NUM
dpc-1565	89	2	.	.	PUNCT
dpc-1565	90	1	21(8	21(8	NUM
dpc-1565	90	2	)	)	PUNCT
dpc-1565	90	3	.	.	PUNCT
dpc-1565	91	1	doi	doi	NOUN
dpc-1565	91	2	:	:	PUNCT
dpc-1565	91	3	10.3390	10.3390	NUM
dpc-1565	91	4	/	/	SYM
dpc-1565	91	5	molecules21081063	molecules21081063	PROPN
dpc-1565	91	6	.	.	PUNCT
dpc-1565	92	1	pmid	pmid	NOUN
dpc-1565	92	2	:	:	PUNCT
dpc-1565	92	3	27529209	27529209	NUM
dpc-1565	92	4	3	3	NUM
dpc-1565	92	5	.	.	PUNCT
dpc-1565	92	6	williams	williams	PROPN
dpc-1565	92	7	hc	hc	PROPN
dpc-1565	92	8	,	,	PUNCT
dpc-1565	92	9	dellavalle	dellavalle	NOUN
dpc-1565	92	10	rp	rp	NOUN
dpc-1565	92	11	,	,	PUNCT
dpc-1565	92	12	and	and	CCONJ
dpc-1565	92	13	garner	garner	PROPN
dpc-1565	92	14	s.	s.	PROPN
dpc-1565	92	15	acne	acne	PROPN
dpc-1565	92	16	vulgaris	vulgaris	PROPN
dpc-1565	92	17	.	.	PUNCT
dpc-1565	93	1	lancet	lancet	PROPN
dpc-1565	93	2	.	.	PUNCT
dpc-1565	94	1	2012	2012	NUM
dpc-1565	94	2	.	.	PUNCT
dpc-1565	95	1	379(9813	379(9813	NUM
dpc-1565	95	2	):	):	PUNCT
dpc-1565	95	3	361	361	NUM
dpc-1565	95	4	-	-	SYM
dpc-1565	95	5	72	72	NUM
dpc-1565	95	6	.	.	PUNCT
dpc-1565	96	1	doi	doi	NOUN
dpc-1565	96	2	:	:	PUNCT
dpc-1565	96	3	10.1016	10.1016	NUM
dpc-1565	96	4	/	/	SYM
dpc-1565	96	5	s0140	s0140	PROPN
dpc-1565	96	6	-	-	PUNCT
dpc-1565	96	7	6736(11)60321	6736(11)60321	NUM
dpc-1565	96	8	-	-	SYM
dpc-1565	96	9	8	8	NUM
dpc-1565	96	10	4	4	NUM
dpc-1565	96	11	.	.	PUNCT
dpc-1565	97	1	moradi	moradi	PROPN
dpc-1565	97	2	tuchayi	tuchayi	PROPN
dpc-1565	97	3	s	s	PROPN
dpc-1565	97	4	,	,	PUNCT
dpc-1565	97	5	et	et	PROPN
dpc-1565	97	6	al	al	PROPN
dpc-1565	97	7	.	.	PUNCT
dpc-1565	98	1	acne	acne	PROPN
dpc-1565	98	2	vulgaris	vulgaris	PROPN
dpc-1565	98	3	.	.	PUNCT
dpc-1565	99	1	nat	nat	PROPN
dpc-1565	99	2	rev	rev	VERB
dpc-1565	99	3	dis	dis	PROPN
dpc-1565	99	4	primers	primer	NOUN
dpc-1565	99	5	.	.	PUNCT
dpc-1565	100	1	2015	2015	NUM
dpc-1565	100	2	.	.	PUNCT
dpc-1565	101	1	1	1	NUM
dpc-1565	101	2	:	:	SYM
dpc-1565	101	3	15029	15029	NUM
dpc-1565	101	4	.	.	PUNCT
dpc-1565	102	1	doi	doi	NOUN
dpc-1565	102	2	.	.	PUNCT
dpc-1565	102	3	10.1038	10.1038	NUM
dpc-1565	102	4	/	/	SYM
dpc-1565	102	5	nrdp.2015.29	nrdp.2015.29	NOUN
dpc-1565	102	6	.	.	PUNCT
dpc-1565	103	1	pmid	pmid	NOUN
dpc-1565	103	2	:	:	PUNCT
dpc-1565	103	3	27189872	27189872	NUM
dpc-1565	103	4	5	5	NUM
dpc-1565	103	5	.	.	PUNCT
dpc-1565	104	1	hidalgo	hidalgo	PROPN
dpc-1565	104	2	e	e	PROPN
dpc-1565	104	3	,	,	PUNCT
dpc-1565	104	4	bartolome	bartolome	PROPN
dpc-1565	104	5	r	r	PROPN
dpc-1565	104	6	,	,	PUNCT
dpc-1565	104	7	dominguez	dominguez	PROPN
dpc-1565	104	8	c.	c.	PROPN
dpc-1565	104	9	cytotoxicity	cytotoxicity	NOUN
dpc-1565	104	10	mechanisms	mechanism	NOUN
dpc-1565	104	11	of	of	ADP
dpc-1565	104	12	sodium	sodium	NOUN
dpc-1565	104	13	hypochlorite	hypochlorite	NOUN
dpc-1565	104	14	in	in	ADP
dpc-1565	104	15	cultured	cultured	ADJ
dpc-1565	104	16	human	human	ADJ
dpc-1565	104	17	dermal	dermal	NOUN
dpc-1565	104	18	fibroblasts	fibroblast	NOUN
dpc-1565	104	19	and	and	CCONJ
dpc-1565	104	20	its	its	PRON
dpc-1565	104	21	bactericidal	bactericidal	ADJ
dpc-1565	104	22	effectiveness	effectiveness	NOUN
dpc-1565	104	23	.	.	PUNCT
dpc-1565	105	1	chemico	chemico	ADJ
dpc-1565	105	2	-	-	ADJ
dpc-1565	105	3	biological	biological	ADJ
dpc-1565	105	4	interactions	interaction	NOUN
dpc-1565	105	5	.	.	PUNCT
dpc-1565	106	1	2002	2002	NUM
dpc-1565	106	2	.	.	PUNCT
dpc-1565	107	1	139(3	139(3	NUM
dpc-1565	107	2	):	):	PUNCT
dpc-1565	107	3	265	265	NUM
dpc-1565	107	4	-	-	SYM
dpc-1565	107	5	282	282	NUM
dpc-1565	107	6	.	.	PUNCT
dpc-1565	108	1	doi	doi	NOUN
dpc-1565	108	2	:	:	PUNCT
dpc-1565	108	3	10.1016	10.1016	NUM
dpc-1565	108	4	/	/	SYM
dpc-1565	108	5	s0009	s0009	PROPN
dpc-1565	108	6	-	-	PUNCT
dpc-1565	108	7	2797(02)00003	2797(02)00003	NOUN
dpc-1565	108	8	-	-	PUNCT
dpc-1565	108	9	0	0	NUM
dpc-1565	108	10	.	.	NOUN
dpc-1565	108	11	6	6	NUM
dpc-1565	108	12	.	.	X
dpc-1565	109	1	eriksson	eriksson	PROPN
dpc-1565	109	2	s	s	PROPN
dpc-1565	109	3	,	,	PUNCT
dpc-1565	109	4	et	et	PROPN
dpc-1565	109	5	al	al	PROPN
dpc-1565	109	6	.	.	PROPN
dpc-1565	109	7	antibacterial	antibacterial	ADJ
dpc-1565	109	8	and	and	CCONJ
dpc-1565	109	9	antibiofilm	antibiofilm	NOUN
dpc-1565	109	10	effects	effect	NOUN
dpc-1565	109	11	of	of	ADP
dpc-1565	109	12	sodium	sodium	NOUN
dpc-1565	109	13	hypochlorite	hypochlorite	NOUN
dpc-1565	109	14	against	against	ADP
dpc-1565	109	15	staphylococcus	staphylococcus	NOUN
dpc-1565	109	16	aureus	aureus	NOUN
dpc-1565	109	17	isolates	isolate	NOUN
dpc-1565	109	18	derived	derive	VERB
dpc-1565	109	19	from	from	ADP
dpc-1565	109	20	patients	patient	NOUN
dpc-1565	109	21	with	with	ADP
dpc-1565	109	22	atopic	atopic	NOUN
dpc-1565	109	23	dermatitis	dermatitis	NOUN
dpc-1565	109	24	.	.	PUNCT
dpc-1565	110	1	br	br	PROPN
dpc-1565	110	2	j	j	PROPN
dpc-1565	110	3	dermatol	dermatol	NOUN
dpc-1565	110	4	.	.	PUNCT
dpc-1565	111	1	2017	2017	NUM
dpc-1565	111	2	.	.	PUNCT
dpc-1565	112	1	177(2	177(2	NUM
dpc-1565	112	2	):	):	PUNCT
dpc-1565	112	3	513521	513521	NUM
dpc-1565	112	4	.	.	PUNCT
dpc-1565	113	1	doi	doi	NOUN
dpc-1565	113	2	:	:	PUNCT
dpc-1565	113	3	10.1111	10.1111	NUM
dpc-1565	113	4	/	/	SYM
dpc-1565	113	5	bjd.15410	bjd.15410	PROPN
dpc-1565	113	6	.	.	PUNCT
dpc-1565	114	1	pmid	pmid	NOUN
dpc-1565	114	2	:	:	PUNCT
dpc-1565	114	3	28238217	28238217	NUM
dpc-1565	114	4	7	7	NUM
dpc-1565	114	5	.	.	PUNCT
dpc-1565	114	6	hunter	hunter	PROPN
dpc-1565	114	7	dt	dt	PROPN
dpc-1565	114	8	.	.	PUNCT
dpc-1565	114	9	sodium	sodium	NOUN
dpc-1565	114	10	hypochlorite	hypochlorite	NOUN
dpc-1565	114	11	in	in	ADP
dpc-1565	114	12	the	the	DET
dpc-1565	114	13	treatment	treatment	NOUN
dpc-1565	114	14	of	of	ADP
dpc-1565	114	15	herpes	herpe	NOUN
dpc-1565	114	16	simplex	simplex	NOUN
dpc-1565	114	17	virus	virus	NOUN
dpc-1565	114	18	infections	infection	NOUN
dpc-1565	114	19	.	.	PUNCT
dpc-1565	115	1	cutis	cutis	NOUN
dpc-1565	115	2	.	.	PUNCT
dpc-1565	116	1	1983	1983	NUM
dpc-1565	116	2	.	.	PUNCT
dpc-1565	117	1	31(3	31(3	NUM
dpc-1565	117	2	):	):	PUNCT
dpc-1565	117	3	328	328	NUM
dpc-1565	117	4	-	-	SYM
dpc-1565	117	5	32	32	NUM
dpc-1565	117	6	.	.	PUNCT
dpc-1565	118	1	8	8	NUM
dpc-1565	118	2	.	.	X
dpc-1565	118	3	del	del	PROPN
dpc-1565	118	4	rosso	rosso	PROPN
dpc-1565	118	5	jq	jq	PROPN
dpc-1565	118	6	and	and	CCONJ
dpc-1565	118	7	bhatia	bhatia	PROPN
dpc-1565	118	8	n.	n.	PROPN
dpc-1565	118	9	status	status	PROPN
dpc-1565	118	10	report	report	NOUN
dpc-1565	118	11	on	on	ADP
dpc-1565	118	12	topical	topical	ADJ
dpc-1565	118	13	hypochlorous	hypochlorous	ADJ
dpc-1565	118	14	acid	acid	NOUN
dpc-1565	118	15	:	:	PUNCT
dpc-1565	118	16	clinical	clinical	ADJ
dpc-1565	118	17	relevance	relevance	NOUN
dpc-1565	118	18	of	of	ADP
dpc-1565	118	19	specific	specific	ADJ
dpc-1565	118	20	formulations	formulation	NOUN
dpc-1565	118	21	,	,	PUNCT
dpc-1565	118	22	potential	potential	ADJ
dpc-1565	118	23	modes	mode	NOUN
dpc-1565	118	24	of	of	ADP
dpc-1565	118	25	action	action	NOUN
dpc-1565	118	26	,	,	PUNCT
dpc-1565	118	27	and	and	CCONJ
dpc-1565	118	28	study	study	VERB
dpc-1565	118	29	outcomes	outcome	NOUN
dpc-1565	118	30	.	.	PUNCT
dpc-1565	119	1	j	j	PROPN
dpc-1565	119	2	clin	clin	PROPN
dpc-1565	119	3	aesthet	aesthet	PROPN
dpc-1565	119	4	dermatol	dermatol	PROPN
dpc-1565	119	5	.	.	PUNCT
dpc-1565	120	1	2018	2018	NUM
dpc-1565	120	2	.	.	PUNCT
dpc-1565	121	1	11(11	11(11	NUM
dpc-1565	121	2	):	):	PUNCT
dpc-1565	121	3	36	36	NUM
dpc-1565	121	4	-	-	SYM
dpc-1565	121	5	39	39	NUM
dpc-1565	121	6	.	.	PUNCT
dpc-1565	122	1	9	9	NUM
dpc-1565	122	2	.	.	X
dpc-1565	123	1	coetzee	coetzee	PROPN
dpc-1565	123	2	e	e	PROPN
dpc-1565	123	3	,	,	PUNCT
dpc-1565	123	4	et	et	PROPN
dpc-1565	123	5	al	al	PROPN
dpc-1565	123	6	.	.	PUNCT
dpc-1565	124	1	the	the	DET
dpc-1565	124	2	use	use	NOUN
dpc-1565	124	3	of	of	ADP
dpc-1565	124	4	topical	topical	ADJ
dpc-1565	124	5	,	,	PUNCT
dpc-1565	124	6	un	un	ADJ
dpc-1565	124	7	-	-	ADJ
dpc-1565	124	8	buffered	buffer	VERB
dpc-1565	124	9	sodium	sodium	NOUN
dpc-1565	124	10	hypochlorite	hypochlorite	NOUN
dpc-1565	124	11	in	in	ADP
dpc-1565	124	12	the	the	DET
dpc-1565	124	13	management	management	NOUN
dpc-1565	124	14	of	of	ADP
dpc-1565	124	15	burn	burn	NOUN
dpc-1565	124	16	wound	wound	ADJ
dpc-1565	124	17	infection	infection	NOUN
dpc-1565	124	18	.	.	PUNCT
dpc-1565	125	1	burns	burn	NOUN
dpc-1565	125	2	.	.	PUNCT
dpc-1565	125	3	2012	2012	NUM
dpc-1565	125	4	.	.	PUNCT
dpc-1565	126	1	38(4	38(4	NUM
dpc-1565	126	2	):	):	PUNCT
dpc-1565	126	3	529	529	NUM
dpc-1565	126	4	-	-	SYM
dpc-1565	126	5	33	33	NUM
dpc-1565	126	6	.	.	PUNCT
dpc-1565	127	1	doi	doi	NOUN
dpc-1565	127	2	:	:	PUNCT
dpc-1565	127	3	10.1016	10.1016	NUM
dpc-1565	127	4	/	/	SYM
dpc-1565	127	5	j.burns.2011.10.008	j.burns.2011.10.008	PROPN
dpc-1565	127	6	.	.	PUNCT
dpc-1565	128	1	pmid	pmid	NOUN
dpc-1565	128	2	:	:	PUNCT
dpc-1565	128	3	22100425	22100425	NUM
dpc-1565	128	4	10	10	NUM
dpc-1565	128	5	.	.	PUNCT
dpc-1565	129	1	bagatin	bagatin	PROPN
dpc-1565	129	2	e	e	PROPN
dpc-1565	129	3	,	,	PUNCT
dpc-1565	129	4	et	et	PROPN
dpc-1565	129	5	al	al	PROPN
dpc-1565	129	6	.	.	PUNCT
dpc-1565	129	7	adult	adult	ADJ
dpc-1565	129	8	female	female	ADJ
dpc-1565	129	9	acne	acne	NOUN
dpc-1565	129	10	:	:	PUNCT
dpc-1565	129	11	a	a	DET
dpc-1565	129	12	guide	guide	NOUN
dpc-1565	129	13	to	to	ADP
dpc-1565	129	14	clinical	clinical	ADJ
dpc-1565	129	15	practice	practice	NOUN
dpc-1565	129	16	.	.	PUNCT
dpc-1565	130	1	anais	anais	PROPN
dpc-1565	130	2	brasileiros	brasileiros	PROPN
dpc-1565	130	3	de	de	PROPN
dpc-1565	130	4	dermatologia	dermatologia	PROPN
dpc-1565	130	5	.	.	PUNCT
dpc-1565	131	1	2019	2019	NUM
dpc-1565	131	2	.	.	PUNCT
dpc-1565	132	1	94(1	94(1	NUM
dpc-1565	132	2	):	):	PUNCT
dpc-1565	132	3	62	62	NUM
dpc-1565	132	4	-	-	SYM
dpc-1565	132	5	75	75	NUM
dpc-1565	132	6	.	.	PUNCT
dpc-1565	133	1	doi	doi	PROPN
dpc-1565	133	2	.	.	PROPN
dpc-1565	133	3	10.1590	10.1590	NUM
dpc-1565	133	4	/	/	SYM
dpc-1565	133	5	abd1806	abd1806	NOUN
dpc-1565	133	6	-	-	PUNCT
dpc-1565	133	7	4841.20198203	4841.20198203	NUM
dpc-1565	133	8	.	.	PUNCT
dpc-1565	134	1	pmid	pmid	NOUN
dpc-1565	134	2	:	:	PUNCT
dpc-1565	134	3	30726466	30726466	NUM
dpc-1565	134	4	11	11	NUM
dpc-1565	134	5	.	.	PUNCT
dpc-1565	135	1	preneau	preneau	PROPN
dpc-1565	135	2	s.	s.	PROPN
dpc-1565	135	3	and	and	CCONJ
dpc-1565	135	4	dreno	dreno	ADJ
dpc-1565	135	5	b.	b.	PROPN
dpc-1565	135	6	female	female	ADJ
dpc-1565	135	7	acne	acne	NOUN
dpc-1565	135	8	a	a	DET
dpc-1565	135	9	different	different	ADJ
dpc-1565	135	10	subtype	subtype	NOUN
dpc-1565	135	11	of	of	ADP
dpc-1565	135	12	teenager	teenager	NOUN
dpc-1565	135	13	acne	acne	NOUN
dpc-1565	135	14	?	?	PUNCT
dpc-1565	136	1	j	j	PROPN
dpc-1565	136	2	eur	eur	PROPN
dpc-1565	136	3	acad	acad	PROPN
dpc-1565	136	4	dermatol	dermatol	NOUN
dpc-1565	136	5	venereol	venereol	NOUN
dpc-1565	136	6	.	.	PUNCT
dpc-1565	137	1	2012	2012	NUM
dpc-1565	137	2	.	.	PUNCT
dpc-1565	138	1	26(3	26(3	NUM
dpc-1565	138	2	):	):	PUNCT
dpc-1565	138	3	27782	27782	NUM
dpc-1565	138	4	.	.	PUNCT
dpc-1565	139	1	doi	doi	NOUN
dpc-1565	139	2	:	:	PUNCT
dpc-1565	139	3	10.1111	10.1111	NUM
dpc-1565	139	4	/	/	SYM
dpc-1565	139	5	j.1468	j.1468	NOUN
dpc-1565	139	6	-	-	PUNCT
dpc-1565	139	7	3083.2011.04214.x	3083.2011.04214.x	NUM
dpc-1565	139	8	pmid	pmid	NOUN
dpc-1565	139	9	:	:	PUNCT
dpc-1565	139	10	21848892	21848892	NUM
dpc-1565	139	11	12	12	NUM
dpc-1565	139	12	.	.	PUNCT
dpc-1565	140	1	hilerowicz	hilerowicz	PROPN
dpc-1565	140	2	y	y	PROPN
dpc-1565	140	3	,	,	PUNCT
dpc-1565	140	4	et	et	PROPN
dpc-1565	140	5	al	al	PROPN
dpc-1565	140	6	.	.	PUNCT
dpc-1565	141	1	thermomechanical	thermomechanical	ADJ
dpc-1565	141	2	ablation	ablation	NOUN
dpc-1565	141	3	-	-	PUNCT
dpc-1565	141	4	assisted	assist	VERB
dpc-1565	141	5	photodynamic	photodynamic	ADJ
dpc-1565	141	6	therapy	therapy	NOUN
dpc-1565	141	7	for	for	ADP
dpc-1565	141	8	the	the	DET
dpc-1565	141	9	treatment	treatment	NOUN
dpc-1565	141	10	of	of	ADP
dpc-1565	141	11	acne	acne	NOUN
dpc-1565	141	12	vulgaris	vulgaris	NOUN
dpc-1565	141	13	.	.	PUNCT
dpc-1565	142	1	a	a	DET
dpc-1565	142	2	retrospective	retrospective	ADJ
dpc-1565	142	3	chart	chart	NOUN
dpc-1565	142	4	review	review	NOUN
dpc-1565	142	5	of	of	ADP
dpc-1565	142	6	30	30	NUM
dpc-1565	142	7	patients	patient	NOUN
dpc-1565	142	8	.	.	PUNCT
dpc-1565	143	1	lasers	laser	NOUN
dpc-1565	143	2	in	in	ADP
dpc-1565	143	3	surgery	surgery	NOUN
dpc-1565	143	4	and	and	CCONJ
dpc-1565	143	5	medicine	medicine	NOUN
dpc-1565	143	6	.	.	PUNCT
dpc-1565	144	1	n	n	CCONJ
dpc-1565	144	2	/	/	SYM
dpc-1565	144	3	a(n	a(n	NOUN
dpc-1565	144	4	/	/	SYM
dpc-1565	144	5	a	a	NOUN
dpc-1565	144	6	)	)	PUNCT
dpc-1565	144	7	.	.	PUNCT